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Abstract:
Transcription factors are important control points in the
patterning of the developing central nervous system. In order to
understand how transcription factors function in fate determination,
it is necessary to study transcriptional changes which are closely
linked to changes in the determination state of the multipotential
precursor cells. These cells can be identified by the expression of the
intermediate filament nestin, and the nestin gene is sharply down-
regulated upon the differentiation of precursors to neurons or glia.
Expression of nestin in the central nervous system is dependent upon
an enhancer located in the second intron of the gene. In this thesis,
the nestin CNS-specific enhancer has been mapped to a 257 base pair
region which is sufficient for expression throughout the embryonic
neuroepithelium. This element also drives correct onset of expression
in the embryonic neural tube and down-regulation in migrating
post-mitotic neurons. Analysis of protein binding to the enhancer in
vitro has revealed five sites which are recognized by nuclear
proteins derived from embryonic CNS tissues. Each of these five sites
interacts with multiple binding activities, with complex temporal and
tissue distributions. Sequence comparison of the binding sites with
known cis-element motifs suggests that the nestin enhancer contains
two recognition sites for POU transcription factors, two sites for the
AP-2 family, and one site possibly related to the cyclic AMP response
element or the half-site for non-steroid nuclear hormone receptors.
Antibody supershift assays demonstrate that the two POU sites are
each bound by the CNS-specific transcription factors Brn-l and
Brn-2.
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The development of the vertebrate central nervous system
resembles the history of the Union Jack, the flag of the United
Kingdom. The emblem of England has long been a simple upright red
cross on a white field, the cross of St. George. At the beginning of the
seventeenth century this flag was overlaid upon the diagonal white
cross on blue of St. Andrew, to celebrate the union of England and
Scotland. Two hundred years later the diagonal red cross on white of
St. Patrick, patron saint of Ireland, was superimposed upon the other
two crosses to form the complex pattern of the Union Jack, a symbol
of unity among three nations.
The central nervous system is similarly fashioned by
superimposing simple patterns to produce a complex design. In this
case, we are talking about patterns of gene expression. The large
number of differentiated cell types of the mammalian brain are
produced in a cascade of determination steps in which the potential
fates of totipotent embryonic cells are progressively restricted.
Inductive events or intrinsic programs restrict cell fates by altering
gene expression in a region of the embryo to set it apart from a more
general region. These fate restrictions are implemented by
transcription factors, which drive changes in overall gene expression
at each determination step.
No transcription factor has yet been found which is active in
only one of the many cell types of the central nervous system.
Rather, it seems that a given cell type is established by the combined
effects of numerous transcription factors over the course of
development. However, it may be possible to dissect apart the
overlapping patterns, as many Scottish and Irish people have
suggested doing. By concentrating on one crucial stage of
development, we can discover simple patterns underlying the whole.
For this reason, the intermediate filament nestin provides an
opportunity to look for transcription factors involved in generation of
the central nervous system (CNS). The expression of nestin in the CNS
is largely limited to multipotential precursor cells, and is tightly
correlated to the proliferating cell state. While there is no evidence
that intermediate filaments are necessary for the development of
any cell type, it is likely that the upstream signals which activate or
de-activate nestin are also involved in determination steps which
affect neuroepithelial precursor cells.
Brief summary of CNS development, with overemphasis on
transcription factors
The vertebrate central nervous system is formed by interaction
between the mesodermal and ectodermal layers of the embryo. A
region of dorsal mesoderm called the organizer or Hensen's node
signals ectodermal cells to become neural, and also specifies the
anteroposterior (A/P) axis of the embryo. Formation of the organizer
in Xenopus embryos is dependent on physical rearrangements such
as cortical rotation which specifies the dorsoventral polarity of the
embryo [Black and Gerhart, 1985], and interactions between the
animal and vegetal poles. A number of transcription factors are
associated with the organizer. These include the homeobox gene
goosecoid, which is expressed in mesodermal cells in the organizer
region, and which can duplicate organizer activity when goosecoid
mRNA is injected into Xenopus embryos [Cho et al., 1991]. However,
goosecoid is not required for gastrulation or neurulation in mice;
knockout animals merely have craniofacial and rib abnormalities
[Rivera-Perez et al., 1995; Yamada et al., 1995]. In addition, two
Xenopus winged-helix factors, Xenopus fork head and pintallavis, are
transcribed in the dorsal blastopore lip [Dirksen and Jamrich, 1992;
Ruiz i Altaba and Jessell, 1992]. Additionally, a maternally
transcribed LIM-domain factor, Xlim-1, is localized to dorsal
mesoderm during gastrulation, and can promote neural or muscle
differentiation if the inhibitory LIM domains are mutated [Taira et
al., 1994].
The organizer is the source of neural inducing signals which
travel both vertically from axial mesoderm to overlying ectoderm
and horizontally through the ectoderm. Vertical signals from
chordamesoderm induce neural tissue with the same A/P value
[Mangold, 1933], but planar signals traveling through the neural
plate from posterior mesoderm can also induce a nearly complete
A/P axis in exogastrulae or Keller explants [Doniach et al., 1992;
Papalopulu and Kintner, 1993; Ruiz i Altaba, 1992]. Cooperation of
both kinds of signals is necessary for formation of certain structures,
such as the eyes [Dixon and Kintner, 1989].
While planar signals alone can induce neural tissue, vertical
signals are necessary for folding of the neural tube. For example, the
notochord promotes bending of the neural plate by inducing medial
cells to adopt a wedge-like shape [Smith and Schoenwolf, 1989; Van
Straaten et al., 1988]. However, intrinsic forces are also necessary for
neurulation and appear to be generated by microfilaments and
microtubules and to require internal calcium [reviewed by Jacobson,
1991]. Although the intermediate filament nestin is present during
this process (see next subheading), it is not known to have a role in
neurulation.
Both vertical and lateral signals are also involved in the
mediolateral regionalization of the neural tube. The underlying
notochord and prechordal mesoderm induce formation of the
floorplate [Placzek et al., 1990; Yamada et al., 1991]. Notochord and
floorplate can each induce ventral fates in the neural tube; these
regions co-express the diffusible factor sonic hedgehog and the
transcription factors HNF3cc and HNF31 (Xenopus Pintallavis) [Ruiz i
Altaba, 1994]. These signals also influence the expression patterns of
the dorsally expressed transcription factors Pax-3 and Pax-7
[Goulding et al., 1993]. Additional signals from the nonneural
ectoderm signal the lateral neural plate cells to adopt dorsal fates;
these signals include BMP-4 [Liem et al., 1995].
The molecular nature of the neural inducing signals is just
beginning to be understood. Two candidate neural inducers are the
secreted polypeptides noggin and follistatin. Both are expressed in
the organizer region and later in the notochord [Hemmati-Brivanlou
et al., 1994; Smith and Harland, 1992]. Each appears to act
independently of the other, and can directly induce ectoderm to
express both general and anterior neural markers but not caudal
markers [Hemmati-Brivanlou et al., 1994; Lamb et al., 1993]. There is
evidence that neural differentiation is actually the default pathway
for animal cap cells [Grunz and Tackle, 1989; Sato and Sargent, 1989];
the function of follistatin may be to bind and inhibit activin or a
related TGFP family member which inhibits the neural fate
[Hemmati-Brivanlou and Melton, 1994].
The fact that noggin and follistatin cannot induce posterior
neural tissue is in keeping with several earlier models of neural
induction. It has been proposed that the A/P pattern of the CNS
arises in at least two steps: the first step induces neural tissue with
anterior potential, and a subsequent step transforms part of this to
posterior neural tissue [Nieuwkoop, 1952]. Experiments in which
anterior neural plate tissue was mixed in various ratios with
posterior mesoderm suggest that intermediate neural structures are
induced by a signal gradient from the mesoderm [Toivonen and
Sax6n, 1968]. However, the signalling molecule detected in this
experiment is thought to be activin, which acts indirectly on neural
tissue by inducing dorsal mesoderm [reviewed by Gilbert and Saxen,
1993]. More recent models propose that caudalizing signals diffuse
through the plane of the ectoderm. One potential caudalizing signal is
basic fibroblast growth factor (bFGF). bFGF is able to induce posterior
neural markers in isolated animal caps [Cox and Hemmati-Brivanlou,
1995; Lamb and Harland, 1995] or anterior and posterior markers in
a dose-dependent manner [Kengaku and Okamoto, 1995], but may be
required to cooperate with anterior inducers in order to do so
[reviewed by Doniach, 1995].
Retinoic acid (RA) is another potential caudalizing signal.
Endogenous RA is detected in Xenopus gastrulae and neurulae
[Durston et al., 1989], and exhibits a ten-fold difference from
posterior to anterior ends of neurulae [Chen et al., 1994]. Exposure of
embryos to exogenous retinoic acid truncates the A/P axis, and also
respecifies the expression domains of region-specific markers
[Durston et al., 1989; Sive et al., 1990]. RA affects both the A/P
values signalled by the mesoderm and the ability of the ectoderm to
respond [Sive and Cheng, 1991]. The responsive period of the embryo
to RA is limited; embryonic tissues gradually lose their sensitivity to
RA from the gastrula to early neurula stages [Sive et al., 1990]. This
suggests that the A/P pattern must be actively maintained by
signalling from gastrulation until committment occurs in the neurula.
The receptors for retinoic acid are transcription factors and members
of the nuclear receptor superfamily.
In the developing hindbrain, retinoic acid exerts its patterning
effect in part by altering the expression of homeobox transcription
factors [Marshall et al., 1992]. The sixty amino acid homeobox DNA-
binding domain is common to several protein families, but was first
described in the Drosophila antennapedia and bithorax clusters
which control segment identity. The mammalian homologues of these
clusters are the Hox genes, whose role in the CNS is to specify the
identity of several hindbrain segments [McGinnis and Krumlauf,
1992]. However, the Hox genes are not expressed anterior to the
hindbrain. Patterning of the forebrain and midbrain may depend
upon other homeobox genes: Otx2 appears very early in the anterior
neural plate, and forms a nested set of expression patterns in the
forebrain and midbrain with Otxl, Emxl, and Emx2 [Simeone et al.,
1992]. Otx2 expression is also repressed by retinoic acid [Simeone et
al., 1995]. Targeted disruption of Otx2 in mice produces embryos
lacking the forebrain and midbrain regions [Acampora et al., 1995].
Additionally, there is a great deal of evidence that specification
or maintenance of the A/P axis is carried out by the neuroepithelial
cells themselves. This has been observed in experiments in which
portions of the neural plate were removed or rotated. Roach repeated
experiments of Spemann, in which a large piece of the anterior
neural plate is rotated 180 degrees with respect to the rostrocaudal
axis; the grafted tissue develops according to its original orientation
[Roach, 1945]. However, Slidecek performed a similar rotation of
neuroepithelium and found complete respecification of the A/P and
mediolateral axes up to the early neurula stages [SlIdecek, 1955].
This difference may be because neural fold regions were not
included in the latter experiment, or due to the smaller graft size;
respecification of the axes is more common in smaller grafts
[Jacobson, 1991]. However, recent studies on transplantation of tissue
pieces or dissociated cells suggest that neuroepithelial cells are not
committed to a regional fate; for example, dissociated cells from the
postnatal cerebellum can integrate into the postnatal hippocampus
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and differentiate in accord with their new position[Vicario-Abej6n,
1995 #309; and references therein]. This suggests that individual
precursor cells are not committed to a regional fate. Rather, active
intercellular signalling maintains regional specifications long after
the neurula stage.
Regionalization of the nervous system is quite well understood
in the fruitfly. Studies have identified several distinct processes in
Drosophila CNS formation, each of which is regulated by numerous
interacting factors. The Drosophila central nervous system arises
from a neuroectodermal region of the embryo whose dorsal
boundary is determined by the secreted factors decapentaplegic and
short gastrulation, while the ventral boundary depends upon the
expression domains of the transcription factors twist and snail
[reviewed by Doe and Skeath, 1996]. In each hemisegment,
approximately 30 neuroblasts are singled out from this
neuroectodermal region by the opposition of proneural and
neurogenic genes. The proneural genes promote commitment to the
neuroblast fate, while neurogenic genes mediate lateral inhibition of
the neural fate in neighboring cells [Jan and Jan, 1993]. Proneural
genes in the fly include basic-helix-loop-helix (bHLH) transcription
factors of the achaete-scute complex (AS-C) and atonal. The
neurogenic genes include the transmembrane proteins Delta and
Notch, which transmit and receive the inhibitory signal, as well as
the bHLH repressors of the Enhancer-of-split complex (E(spl)-C) and
groucho which inhibit transcription of the AS-C genes [Heitzler et al.,
1996]. In addition, ligand binding to Notch causes an intracellular
fragment to be cleaved from the receptor which can enter the
nucleus and promote transcription of E(spl)-C genes in conjunction
with another neurogenic factor, Suppressor of Hairless [Jarriault et
al., 1995; Kopan et al., 1996; Lecourtois and Schweisguth, 1995].
After their formation, the neuroblasts are instructed by the
proneural genes and the ubiquitously expressed bHLH
proteindaughterless to activate a set of 'neural precursor' genes
including the bHLH factors asense and deadpan [Vaessin et al., 1994].
Many of the genes which specify or inhibit neuroblast fate in
drosophila have homologs in vertebrates. Several vertebrate
homologs of the achaete-scute genes are expressed exclusively in
neural tissues. The Xenopus achaete-scute homolog Xash-3 may have
a role analogous to the Drosophila proneural genes in promoting
neural fate: overexpression of Xash-3 enlarges the neural tube at the
expense of ectodermal cells [Turner and Weintraub, 1994]. Mash-i is
transiently expressed in some proliferating neural precursors, and is
required for formation of olfactory and autonomic neurons [Guillemot
et al., 1993]. However, Mash-I is thought to be necessary for
differentiation of neuronal precursors and not for committment to
the neuronal fate [Sommer et al., 1995]. NeuroD is another bHLH gene
expressed in postmitotic neurons in mouse and Xenopus, which also
appears to promote neural differentiation [Lee et al., 1995].
Mammals have homologs of other Drosophila proneural genes as well,
such as the bHLH factors Math-i and Math-2 which are related to
atonal and are expressed in the nervous system [Akazawa et al.,
1995; Shimizu et al., 1995].
Vertebrates also have numerous homologs of the Drosophila
neurogenic genes, some of which are comparable in function.
Multiple homologs of Notch have been found in mammals, zebrafish,
and chick, as well as homologs of the Drosophila ligands Delta and
Serrate [reviewed in Lewis, 1996]. The expression patterns of Notch-
1 and Delta-i in chick and frogs is consistent with a role in lateral
inhibition, as Notch-i is expressed throughout the proliferating
regions of the CNS while Delta-1 is restricted to postmitotic cells
which appear to be newborn neurons [Chitnis et al., 1995; Myat et al.,
1996]. Moreover, in the chick retina Notch and Delta can be directly
shown to regulate the production of neurons [Austin et al., 1995].
This apparent conservation of function extends to another neurogenic
gene: the intracellular domain of mammalian Notch cooperates with a
homolog of Suppressor of Hairless to bind promoter regions [Jarriault
et al., 1995].
While many components of lateral inhibition are present in
vertebrates, the role of these molecules in vertebrate development is
not clear. One proposed role of vertebrate proneural and neurogenic
genes is to control the size of the neural plate by regulating the
competence of dorsal ectoderm to respond to neural induction. For
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example, both Xenopus Notch 1 (XN-1) and Xash-3 are expressed in
the dorsal ectoderm during gastrulation, and also in the neural plate
and tube [Coffman et al., 1990; Zimmerna et al., 1993]. However, a
presumably activating mutation of XN-1 enlarges the neural tube
rather than promoting ectodermal fates [Coffman et al., 1993], while
deletion of Mash-1 does not affect the size of the neural tube
[Guillemot et al., 1993]. Of course, many vertebrate homologs of the
proneural and neurogenic genes exist, so unknown homologs may be
involved in neural plate formation. On the other hand, a model has
been proposed in which these genes act after neural plate formation
to control the number of neural precursor cells [Chitnis and Kintner,
1995].
Other transcription factors in the neuroepithelium control the
proliferation of neural precursor cells. The bHLH protein HES-1 is a
homolog of Drosophila hairy and E(spl)-C genes and is a
transcriptional repressor expressed only in the undifferentiated cells
of the ventricular zone; disruption of HES-1 prematurely ends
proliferation of neuronal precursors and causes severe neural tube
defects [Ishibashi et al., 1995]. The winged-helix factor BF-1 also
promotes cell division, but is expressed only in the telencephalic
neuroepithelium and eye structures. Targeted disruption of BF-1
reduces the proliferation of precursor cells and leads to their
premature differentiation, which greatly reduces the size of the
cerebral hemispheres. In addition, these mice may fail to specify
ventral but not dorsal telencephalic cells [Xuan et al., 1995].
During neurogenesis, it has been speculated that the precursor
cells are asymmetrically dividing stem cells, creating one stem cell
and one neuron at each division [Rakic, 1988]. Drosophila neuroblasts
divide asymmetrically to produce a neuroblast and a ganglion
mother cell. The homeodomain transcription factor prospero and the
membrane molecule numb are inherited during mitosis by only the
ganglion mother cell, and may functionally distinguish the mother
from the uncommitted neuroblast [Knoblich et al., 1995; Spana and
Doe, 1995; Spana et al., 1995]. The mouse gene Proxl is a homologue
of prospero expressed in newborn neurons in the subventricular
zone, but it is not yet known to have a role in neural fate
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determination [Oliver et al., 1993]. In the mammalian cortex, unequal
distribution of Notch may differentiate the postmitotic daughter of
an asymmetrically dividing stem cell from the proliferating daughter
[Chenn and McConnell, 1995].
Between their final division and maturity, newborn neurons
must undergo many processes of migration and differentiation which
are also dependent on correct transcription factor expression. First,
the newly postmitotic neurons of the neural tube migrate outward
from the ventricular zone along the processes of radial glia cells
[Rakic, 1972]. A naturally arising mutation in the paired-box gene
Pax-6 disrupts the radial migration of cortical neurons and the
subsequent layering of the cortex [Schmahl et al., 1993]. The same
mutation, when homozygous, blocks eye formation; thus Pax-6 may
be required for the determination of the entire eye structure [Hogan
et al., 1988].
Some transcription factors may have very general roles in
differentiation. The trans-activating activity called AP-1 is elevated
in all regions of the neonatal rat brain but declines to low basal
levels in the adult. AP-1 activity is composed of heterodimeric
proteins of the fos and jun families. These proto-oncogenes are basic
region-leucine zipper (bZIP) transcription factors induced by adult
neurons in response to activating stimuli such as light, odor, and pain
[Pennypacker, 1995]. Fos and jun also have roles in neuronal
differentiation. They are induced by growth factor signals; the first
detectable event in the nerve growth factor (NGF) or epidermal
growth factor (EGF)-induced differentiation of the PC12 cell line is
the transcriptional activation of c-fos [Kruijer et al., 1985]. In
addition, the Drosophila jun homolog specifies the R7 photoreceptor
[Bohmann et al., 1994].
Another family of bZIP transcription factors also mediate a
number of signals in CNS development. The cyclic AMP response
element-binding proteins (CREBs) include at least three genes, called
CREB, CREM, and ATF-1, which have numerous isoforms and can
heterodimerize with one another or jun-related factors. Binding of
CREB to the CRE is constitutive, but the protein has trans-activating
function only when phosphorylated by cAMP-dependent protein
14
kinase (PKA), calcium/calmodulin protein kinase (CaMK), or CREB
kinase (CREBK) [Vallejo, 1994]. Like AP-1, CREB transcriptional
activity is induced in cell lines in response to differentiation signals
such as NGF or transforming growth factor 031 [Ginty et al., 1994;
Kramer et al., 1991].
Other transcription factors are closely associated with the
determination of a few specific cell types. The POU transcription
factor Pit-i is required for the proliferation and maintenance of
three hormone-secreting cell types of the anterior pituitary, and also
transactivates the hormone genes specific to each cell type [Li et al.,
1990]. Another POU transcription factor, brain-2 (Brn-2), is required
for late steps in the maturation of just three neuronal cell types in
the hypothalamus [Nakai et al., 1995; Schonemann et al., 1995].
However, Pit-1, Brn-2 and several other POU genes are also
expressed widely in the early CNS, at the time of neural tube closure
[Treacy and Rosenfeld, 1992]. The combinatorial pattern of POU
genes may be involved in regionalization of the neural tube,
assuming this early function is masked in mutant animals by the
compensating effects of other factors [Alvarez-Bolado et al., 1995]
(see chapter IV for an in-depth discussion of POU factors).
Finally, a wide variety of transcription factors are expressed in
the mature cell types of the adult CNS. Many show preferential
expression in certain cell types, such as the POU gene Brn-5/Emb in
layer IV of the cortex [Andersen et al., 1993], or the lin-11/Isl-
1/mec-3 (LIM) family member Isl-1 in motor neurons of the spinal
cord and brainstem [Thor et al., 1991]. However, no transcription
factors have yet been found to be expressed only in a specific type of
neuron. Therefore it is unlikely that mature neuronal phenotypes are
specified by unique trans-acting factors; rather, combinations of
transcription factors probably specify the identity of cells in the
nervous system.
Nestin marks proliferating precursor cells in the CNS
It is apparent that a large number of transcription factors are
expressed during development of the central nervous system. In
order to identify a few factors out of this abundance which are
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critical in the fate choices made by a given cell, it is necessary to
study transcriptional changes which coincide with changes in the
developmental state of that cell. The intermediate filament gene
nestin provides such an opportunity to study the multipotential
precursor cells of the mammalian CNS, as nestin expression is tightly
linked to the transient precursor cell state.
Nestin was originally described in a search for markers of the
neuroepithelial precursor cells. Monoclonal antibodies were made
against the E15 rat neural tube, and one antibody, Rat 401, was
found to stain radial cells spanning the neural tube from ventricle to
pia, including radial glia [Hockfield and McKay, 1985]. The antigen,
later identified as nestin [Lendahl et al., 1990], was also found in
some non-neuronal cells of the peripheral nervous system and in
developing muscle of the somitic myotome. Nestin has since been
shown to be transiently expressed in developing muscle and to
colocalize with vimentin and desmin in myoblasts and myotubes
[Kachinsky et al., 1994; Sejersen and Lendahl, 1993]. Rat 401 staining
was not found in the adult brain [Hockfield and McKay, 1985].
The nestin expressing cells of the neural tube are
multipotential precursors to neurons and glia. The Rat 401 epitope
first appears at E10, shortly after final neural tube closure. The
nervous system at this stage is a simple columnar epithelium of
rapidly dividing cells. At Ell to E12, approximately 98% of
dissociated neural tube cells are Rat 401 positive [Frederiksen and
McKay, 1988]; the abundance of nestin sharply declines during
periods of neurogenesis in different regions of the brain. In spinal
cord, the proportion of Rat 401 staining falls between Ell and E16; in
cerebrum, this drop occurs from E16 to E21. This corresponds with
the periods of final mitosis observed for neurons in each region
[Berry et al., 1964; Nornes and Das, 1974]. During the course of
neurogenesis, nestin positive cells were shown to be actively
proliferating [Frederiksen and McKay, 1988]. The very tight
correlation between cell proliferation, neuronal birth, and Rat 401
staining indicates that expression of nestin is strongly linked to the
precursor cell state.
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Although Rat 401 staining is found in less than 0.1% of the cells
of the CNS by the period of maximal gliogenesis after birth
[Frederiksen and McKay, 1988], glial cells can also be derived from
nestin positive precursors. Primary O-2A progenitors for
oligodendrocytes and type II astrocytes express nestin, which is
down-regulated upon differentiation to either fate [Gallo and
Armstrong, 1995]. Cultured neural tube primary cells can transiently
co-express Rat 401 antigen with neurofilaments or glial fibrillary
acidic protein (GFAP), which specifically mark neurons and
astrocytes, respectively [Antanitus et al., 1975; Hirokawa, 1982;
Schnapp and Reese, 1982]. Also, a nestin positive cerebellar cell line
can be induced to express either neuronal or glial markers depending
on culture conditions [Frederiksen et al., 1988].
Thus the monoclonal antibody Rat 401 is believed to detect
multipotential precursor cells in the developing brain. Other studies
have also provided evidence for the existence of multipotential
precursors in the nervous system by the immortalizion of precursor
cells [Bartlett et al., 1988; Evrard et al., 1990; Ryder et al., 1990],
differentiating isolated primary cells in culture [Temple, 1989], or
marking proliferating cells in vivo with dyes or lacZ-transducing
retroviruses [Gray et al., 1988; Turner and Cepko, 1987; Wetts and
Fraser, 1988] (See also Kilpatrick et al., 1995 for a review).
Recently, nestin expression has been found in the adult under
several conditions. Nestin is strongly expressed by reactive
astrocytes in response to brain injury or excitotoxic lesioning [Clarke
et al., 1994; Frisen et al., 1995]. Several kinds of CNS tumors express
nestin, including glioblastomas, primitive neuroectodermal tumors,
and medulloblastomas [Dahlstrand et al., 1992a; Valtz et al., 1991].
Finally, nestin expression is detectable in the normal adult brain. A
population of cells isolated from adult striatum can be induced by
epidermal growth factor (EGF) to proliferate and express nestin in
vitro [Reynolds and Weiss, 1992]. These cells were taken from the
lateral subventricular zone of the adult brain, and are generally
quiescent in vivo [Morshead et al., 1994]. However, they can be
induced to proliferate and migrate in vivo by infusion of EGF; more
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than 95% of these EGF-responsive migrating precursor cells of the
adult brain express nestin [Craig et al., 1996].
Other CNS intermediate filaments are cell-type specific also
As mentioned previously, the antigen for the Rat 401
monoclonal antibody is called nestin, for neuroepithelial stem cell
intermediate filament. The intermediate filament (IF) genes are
grouped on the basis of sequence homology into six types, of which
nestin alone forms type VI [Lendahl et al., 1990]. The other five
classes are: acidic keratins (type I); basic keratins (type II); desmin,
vimentin, peripherin and GFAP (type III); neurofilaments and
a-internexin (type IV); and nuclear lamins (type V). The conserved
locations of the first two introns in the genes for nestin and the
neurofilaments suggest that the two classes are derived from a
common ancestral gene [Dahlstrand et al., 1992b].
Expression of the neurofilament genes, like nestin, is tightly
correlated with the differentiation state of cells in the nervous
system. In fact, throughout the development of neural lineages cells
alter their expression of intermediate filaments with each change in
the cell's developmental potential. This linkage of intermediate
filaments and cell state is well known because it has allowed cell
biologists to follow the process of specification through
immunohistochemistry. Prior to neurulation, the embryonic
epithelium expresses cytokeratins. These are absent from the
neuroepithelium, which coexpresses vimentin and nestin [Bignami et
al., 1982; Hockfield and McKay, 1985]. Both proteins are detected by
antibodies at E10, shortly after neural tube closure; in situ
hybridization, however, reveals that nestin is expressed in the neural
plate by E7.75 in the mouse, at the time the plate first becomes
distinguishable [Dahlstrand et al., 1995]. Later, nestin and vimentin
disappear from newly postmitotic neurons and are absent from
migrating young neurons in the intermediate zone [Bennett, 1987;
Fliegner et al., 1994].
These newly born neurons in the intermediate zone express oa-
internexin and often the light and medium weight neurofilaments
(NF-L and NF-M) [Fliegner et al., 1994]. Expression of the fourth type
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IV IF, NF-H, follows the other two neurofilaments in many neurons
but is absent from a few mature neuronal types. In general, NF-H is
found in projection neurons with large cell bodies, whereas
oa-internexin is the only intermediate filament found in the small
cerebellar granule cells [Fliegner et al., 1994].
The other intermediate filaments of the nervous system are
also highly selective of cell type. GFAP (type III) is found only in
astrocytes and radial glia [Antanitus et al., 1975], while peripherin
(type III) is found in neurons of the peripheral nervous system
(PNS) and some CNS neurons which project to the periphery [Portier
et al., 1983a; Portier et al., 1983b].
Transcriptional regulation of intermediate filament genes
Because nestin and other intermediate filaments of the CNS are
so closely identified with the differentiation state of the cell, the gene
regulation of many intermediate filaments has been studied in hope
of finding how this cell type specificity arises. In cell culture systems,
several intermediate filament genes have been found to have
cis-acting elements which confer expression inducible by known
transcription factors or extracellular growth factors. Astrocyte-
specific expression of the GFAP gene is dependent upon AP-1,
nuclear factor I, and CRE motifs in the proximal promoter [Miura et
al., 1990]. Similarly, the proximal promoter of a-internexin contains
AP-1, AP-2, AP-4, SP1, and octamer binding sites [Ching and Liem,
1991], while the upstream region of the NF-L gene is transactivated
by fos/jun (AP-1) or Krox-24 [Pospelov et al., 1994].
The upstream promoter elements of several IFs mediate the
induction of these genes by extracellular growth factors. These
inductions underscore the link between filaments and cell identity;
several growth factors, including FGF and NGF, act upon
neuroepithelial precursors to affect their survival, proliferation, or
fate choice [reviewed in Kilpatrick et al., 1995]. The upstream
sequences of the NF-M and peripherin genes mediate their induction
by NGF [Zopf et al., 1990]. The human and chicken vimentin genes
are serum-inducible, and this induction is mediated by AP-1 sites
[Carey and Zehner, 1995; Rittling et al., 1989]. The two upstream AP-
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1 sites in the chicken vimentin enhancer flank a unique "antisilencer"
element which is required for induction by FGF [Carey and Zehner,
1995].
The vimentin gene also illustrates that negative cis-acting
elements are important for correct regulation of intermediate
filament genes. The chicken vimentin gene contains three related
silencer elements which bind a 95 kD protein; the abundance of this
protein in vivo increases as vimentin expression drops in maturing
mesoderm [Garzon and Zehner, 1994]. Negative elements have also
been described in the mouse GFAP promoter and the human desmin
(type III IF) promoter, while epidermal keratin genes are negatively
regulated by retinoic acid and thyroid hormone receptors [reviewed
by Oshima, 1992].
Clearly, a wealth of information about intermediate filament
gene regulation has come from cell culture systems. However, the
value of culture models is limited by the fact that several
intermediate filaments are promiscuously expressed in cell lines
derived from non-expressing tissues [Liem, 1993]. Desmin,
a-internexin, and neurofilament light and medium weight genes are
all expressed upon transfection into fibroblasts, although the
endogenous genes are silent. Likewise, a 10 kilobase DNA fragment
encompassing the human keratin 18 gene is correctly expressed in
transgenic mice, but promiscuously expressed in various cell lines
[Oshima, 1992]. Furthermore, the endogenous vimentin gene is
expressed in many cell lines originating from tissues which do not
express vimentin in vivo [Garzon and Zehner, 1994]. This suggests
that native chromatin state plays an important role in silencing
intermediate filament genes.
Reliable information about tissue-specific expression of
intermediate filament genes therefore must be sought from in vivo
assays such as the creation of transgenic mice. Fewer neuronal IF
genes have been studied by this method. Genomic clones of each of
the neurofilament triplet proteins have been shown to give neuron-
specific expression in mice. Correct expression of the NF-L gene
requires the presence of intragenic sequences; independent neuron-
specific enhancers are present in both the first and second introns
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[Beaudet et al., 1992; Charron et al., 1995a]. In addition, the 292 bp
proximal promoter confers independence from insertion site effects.
This phenomenon appears to be related to chromatin structure, as it
requires the presence of a Matrix Attachment Region located in the 3
prime untranslated sequence of reporter transcripts [Charron et al.,
1995b]. Thus correct regulation of NF-L in vivo relies upon several
distinct cis-acting regions.
Similarly, intragenic sequences are required for correct cell-
type specific expression of peripherin in transgenic mice [Belecky-
Adams et al., 1993]. The presence of the introns also allows
upregulation of peripherin following nerve injury. In contrast,
several studies have determined that 2 kilobases of GFAP upstream
sequences are sufficient for both astrocyte-specific expression in
mice and upregulation of the gene following brain injury [Brenner et
al., 1994; Galou et al., 1994; Johnson et al., 1995].
Prior to the beginning of this thesis work, it had been
established that the nestin gene also has multiple independent cis-
acting elements. The upstream flanking sequence and basal promoter
are sufficient for selective expression in nestin positive cell lines, but
not in transgenic mice. Intragenic sequences are required for correct
tissue-specific expression in vivo. The nestin first intron drives
expression in developing muscle of the somites, while the second
intron contains the elements necessary for expression in the
neuroepithelium [Zimmerman et al., 1994]. This neuroepithelial
element within the second intron fits the classical definition of an
enhancer, as it functions independent of position or orientation
relative to a heterologous basal promoter.
In summary, studying the regulation of the nestin gene should
provide insight into the developmental control of neuroepithelial
stem cells in the adult as well as in the embryo. Expression of nestin
is tightly correlated to the precursor cell state, and declines rapidly
with the birth of postmitotic neurons or glia. The discovery of a
tissue-specific element driving neuroepithelial expression of nestin
has provided an opportunity to search for transcriptional control
mechanisms which may directly influence the fate choices being
made by CNS stem cells and their progeny.
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This thesis will discuss:
Chapter II -Localization of the nestin neuroepithelial tissue-specific
element to 257 base pairs
Chapter III -mapping of five potential cis-acting sequences through
protein/DNA interactions in vitro
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Chapter II: Localization of the neural tissue-specific
element of the nestin gene.
Introduction to the nestin neuroepithelial enhancer
The intermediate filament gene nestin has great value to cell
biologists as a marker for multipotent precursor cells. Previous
members of this laboratory recognized that the nestin gene could be
very valuable to molecular biologists as well. They cloned the gene
for nestin from the rat, and determined the approximate location of
the cis-acting transcriptional control regions. Isolation of these
control regions has allowed on-going experiments in which
heterologous genes are mis-expressed in the neuroepithelial
precursor cells for the purpose of marking or manipulating these
cells. In the work presented in this thesis, we have characterized in
detail the transcriptional enhancer which drives expression of nestin
in the central nervous system. Our goal is to identify transcription
factors which have regulatory roles in the fate determination of
neural precursor cells.
Our predecessors began the work of studying the
transcriptional control of nestin by cloning a long stretch of upstream
flanking DNA to look for promoter elements. This 5.8 kilobasepairs
(kb) upstream region was ligated to an E. coli beta galactosidase
(lacZ) reporter gene, and transfected into immortal cerebellar cell
lines to test whether the promoter could confer cell-type specificity.
The cell lines ST15A and ST15I were immortalized at the same time,
under identical conditions; ST15A expresses nestin while ST15I does
not. The nestin upstream reporter plasmid (pNesPlacZ) drives lacZ
expression selectively in ST15A, indicating that this upstream
sequence confers cell-type specificity in vitro [Zimmerman, 1992].
At a later time, 5.3 kb of nestin intragenic sequences were
added to the upstream region/lacZ construct. All three introns of the
rat nestin gene, which are 964 basepairs (bp), 1654 bp, and 194 bp
in length, are included in the intragenic fragment. This fragment was
added downstream of the SV40 polyA site which follows the lacZ
reporter gene, and the plasmid is called pNesPlacZ+3 introns. The
introns have little additional effect in the cell culture assay; their
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presence increased the reporter expression in the nestin-positive cell
line by less than two-fold. It appears that the nestin upstream
flanking region alone is sufficient in vitro.
The same reporter plasmid which was sufficient in cell lines
was then inserted into transient transgenic mice, to test whether the
5.8 kb upstream region could drive expression in all nestin-positive
cells of the CNS, peripheral ganglia, and somites. This assay is called
transient because mouse embryos are analyzed within weeks of DNA
injection, rather than being bred to make stable lines. The upstream
plasmid pNesPlacZ was not correctly expressed in transgenic mice.
Only a few of the transgenic animals turn on the reporter in portions
of the CNS and somites, and the expression is weak, variable and
incomplete [Zimmerman et al., 1994].
Strong and complete tissue-specific expression in transgenic
mice requires the three introns. The plasmid bearing 5.3 kb of nestin
intragenic sequences (pNesPlacZ+3 introns) was strongly expressed in
transient transgenic mice in a pattern closely matching endogenous
nestin expression [Zimmerman et al., 1994]. In embryos, lacZ staining
is present throughout the CNS and in the somites and presomitic
mesoderm. These are the areas which react most strongly to Rat 401
[Hockfield and McKay, 1985]. Furthermore, stable lines made with
pNesPlacZ+3 introns demonstrate the expected onset of reporter gene
expression in the ventral neural tube at E9.0. The lacZ staining at
E10.5 is prominent in the cell bodies and pial endfeet of virtually all
neuroepithelial cells, as is Rat 401. Finally, extinction of reporter
expression takes place at the appropriate ages in various portions of
the CNS. LacZ is gone from spinal cord at E16.5, after neurogenesis is
complete [Nornes and Das, 1974] but is still strong on postnatal day 1
in cerebellum, where neuronal progenitors are still dividing after
birth [Altman, 1972]. Therefore, the intragenic sequences of the
nestin gene are required for correct tissue-specific and
developmental regulation in transgenic mice.
These results demonstrated that the nestin gene contains
multiple transcriptional regulatory elements. While the intragenic
sequences are required for tissue-specific activity in mice, the
upstream region alone is sufficient in a nestin-positive cell line. The
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upstream flanking region seems to have another function in vivo. A
160 bp basal promoter element from the herpes simplex virus
thymidine kinase (TK) gene can also be cis-activated by nestin's
intragenic sequences. Mice with this construct (TKlacZ+3 introns)
show the same expression pattern described above for pNesPlacZ+3
introns. About 60% of mice positive by PCR for the presence of the
TKlacZ+3 introns construct express lacZ in the correct pattern, while
the remainder are lacZ negative. This contrasts with the results for
the native nestin upstream promoter region, which drives proper
lacZ expression in 100% of transgenic mice [Zimmerman et al., 1994].
The contrast between the effectiveness of the TK basal
promoter and the native nestin promoter indicates that the nestin
upstream regions have some sort of activity in vivo. Some possible
interpretations are that the upstream sequence interacts better with
the transcriptional machinery, or binds a factor which increases the
likelihood of transcription. However, this would not adequately
explain why some transgenic mice have very strong reporter
expression overall while others are completely negative. Since every
transient transgenic embryo integrates the injected DNA into a
unique site, the nestin upstream sequences probably insulate the
reporter gene from the influence of the insertion site. Meanwhile,
expression from the TK basal promoter is subject to these position
effects. Perhaps this is due to the greater length of the nestin
sequences, or perhaps the nestin upstream region actively blocks
positional effects on transcription.
Recently, it has begun to be understood how transcriptional
events in the genome can be isolated from position effects. Sequences
called Matrix Attachment Regions (MARs) are thought to organize the
genome into "loop domains" which are insulated from epigenetic
controls acting on the neighboring loops [Chung, 1993]. MARs are
long A/T-rich sequences which bind nuclear matrix, and sometimes
contain various motifs such as topoisomerase II sites, homeobox
binding sites, and regions of kinked or single-stranded DNA. It is
interesting to note that the furthest upstream portion of the cloned
nestin flanking sequences is very A/T rich. The nestin upstream
sequence has not been examined for the other features, nor the
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function, of an MAR, but it is possible that an MAR allows the nestin
upstream sequences to suppress insertion site effects.
Further analysis of the nestin intragenic sequences disclosed
that the gene contains multiple independent regulatory elements
[Zimmerman et al., 1994]. A 1.3 kb fragment encompassing the first
intron was tested in transgenic mice along with the upstream region
(pNesPlacZ+lst intron). This construct drove expression of lacZ
throughout the somites, similar to the staining of muscle precursors
seen with Rat 401.
A similar construct was tested with a 1.8 kb fragment
containing nestin's second intron downstream of the nestin promoter
and lacZ (pNesPlacZ+2nd intron). This plasmid produced transgenic
mice with lacZ staining throughout the embryonic central nervous
system. The pattern and intensity of staining in the neuroepithelium
were very similar to those obtained with pNesPlacZ+3 introns, but no
lacZ was seen in somites. A third construct was made containing the
third intron within a 0.5 kb fragment (pNesPlacZ+3rd intron). This
produced only weak and variable staining identical to that observed
with the nestin upstream alone (pNesPlacZ). Thus the nestin gene
contains two independent tissue-specific regulatory elements, one for
muscle precursors and another for neural precursors, in the first and
second introns respectively.
The second intron element was also added to the basal
promoter plasmid TKlacZ, both upstream and downstream of the
promoter and in either orientation relative to the transcriptional
unit. All of these constructs performed similarly, driving reporter
expression to the neural tube. This neural tissue-specific element
thus meets the classical definition of an enhancer:
"Modular arrays of sequence elements that stimulate
accurate initiation of transcription without strict
requirements for distance or orientation with respect to
the promoter [Hyman et al., 1988]."
The goal of this thesis is to locate the nestin neuroepithelial
enhancer and define it in terms of a "modular array of sequence
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elements" bound by identifiable transcription factors. Chapter II
deals with locating the enhancer within the 1800 base pair fragment
previously defined. We used the transient transgenic mouse assay,
analyzing all constructs for their effects at a single age, E13.5, to
facilitate comparison to the prior data described above. The tissue-
specific elements driving expression in the CNS were localized to a
region of 257 base pairs. Transgenic embryos examined at multiple
ages demonstrate that this 257 bp region reproduces the onset of
nestin expression in the early neural tube, as well as the extinction of
expression in postmitotic neurons.
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Materials And Methods
All standard molecular biology techniques were performed as
described in [Maniatis et al., 1989].
Preparation of Transgenic Mice:
Cesium-chloride purified plasmid DNA was restriction digested to
remove the pUC vector sequences. Enzymes used are listed for each
construct. The digestion reactions were subsequently extracted once
in phenol, once in 25:24:1 phenol/chloroform/isoamyl alcohol, and
once in 24:1 chloroform/isoamyl alcohol. The DNA was concentrated
by ethanol precipitation and layered atop a 10-40% sucrose gradient
in 1 M NaCI, 10 mM Tris-HCl [pH 8.0], 1 mM EDTA. The gradient was
centrifuged 16 hours at 35000 rpm in a Beckmann SW50.1
rotor.100-300 [tL gradient fractions were checked on an agarose gel
for separation of insert from vector. Insert-containing fractions were
pooled and dialyzed in Spectrapor cellulose tubing (MWCO 12000-
14000) versus injection buffer (10 mM Tris-HC1 [pH 8.0], 0.1 mM
EDTA) at 4VC overnight. The dialysed DNA was diluted in injection
buffer to a concentration of 1-5 ng/pgL and sterilized via a 0.22 igM
syringe-tip filter (Millipore Millex-GV4).
Transgenic mice were produced as described by [Hogan et al., 1986].
Embryo donors were C57B16 x C3H F1 female mice, stud males were
C57B16 or C57B16 x C3H Fl, and ICR mice were used as foster
mothers. Incorporation of transgene was assayed (as previously
described by [Zimmerman et al., 1994]) by PCR on yolk sac DNA for
25 cycles of 94°C for 30 s, 55 0 C for 30 s, and 72 0 C for 1 min, using the
primers 5'-TACCACAGCGGATGGTTCGG-3' and
5'-GTGGTGGTTATGCCGATCGC-3'. In the presence of lacZ DNA, a 352
bp product results.
Whole-mount LacZ Procedure:
Embryos were fixed in 0.2% glutaraldehyde, 2 mM MgCl2, 0.1% Triton
X-100 in phosphate-buffered saline (PBS) at room temperature for
60 minutes. They were washed in two changes of PBS plus 2 mM
MgC12, then soaked 20 minutes in PBS plus 2 mM MgC12, 0.1% Triton
X-100, and stained in 1 mg/mL 5-bromo-4-chloro-3-indolyl-3-D-
galactoside (X-Gal), 5mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2,
0.1% Triton X-100 in PBS at 370 C. All embryos were stained for 90
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minutes to three hours, then washed with 70% ethanol to stop the
reaction.
LacZ Staining of Frozen Sections:
Embryos were sacrificed at E16.5 and the brains were removed and
soaked 20% sucrose until loss of buoyancy. The brains were frozen
and cut by cryostat into 40 micron sections, which were collected on
glass slides. The tissue was fixed 40 minutes in 0.2% glutaraldehyde
and processed for X-Gal histochemistry as described above.
Plasmids:
RgllIBbsSpeTKlacZ: The nestin second intron was cut with Spel and
BbsI, which in this case gives a HindII-compatible cohesive end. The
587 bp fragment was isolated using Geneclean II (Biol01l) and
ligated into pBluescript KS+ (Stratagene) digested by SpeI and
HindIII. The resulting plasmid (gIIBSBt) was cut with SalI and NotI.
The 615 bp fragment containing the nestin sequences was isolated
and ligated into SalI and NotI digested pTKlacZ [Zimmerman et al.,
1994]. pUC sequences were removed by digestion with SmaI, NotI
and ScaI prior to injection of embryos.
RglIISalStuTKlacZ: The plasmid RgIItklacZ [Zimmerman et al., 1994]
was cut with StuI and SalI. The overhangs were filled in with Klenow
fragment and religated. pUC sequences were removed by digestion
with SmaI and ScaI prior to injection of embryos.
NsiSalglITKlacZ: The plasmid glItklacZ [Zimmerman et al., 1994] was
cut with NsiI and Sall. The NsiI 3' overhang was blunted with
bacteriophage T4 polymerase, and the Sall 5' overhang was filled in
with Klenow fragment. These blunted ends were religated. pUC
sequences were removed by digestion with SmaI and ScaI prior to
injection of embryos.
NsiSalgIlBt: The plasmid NSglItklacZ was cut with HindIII and BstYI.
An 857 bp fragment containing all the nestin sequence of the
plasmid above was isolated following agarose gel electrophoresis, and
ligated into HindIII and BamHI-digested pBluescript KS+.
SpeSalglITKlacZ: The plasmid NSgIIBt was cut with SpeI. A 770 bp
fragment was isolated and ligated into pTKlacZ digested with SpeI
and dephosphorylated with calf intestinal alkaline phosphatase. pUC
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sequences were removed by digestion with NarI and XmnI prior to
injection of embryos.
ARI-RINSglIItklacZ: NSgIIbt was digested by EcoRI at two sites 70 bp
apart in the nestin second intron and religated. The remaining 777
bp of nestin sequences were cut out with NotI and Sall, and ligated
into Not I and Sal I digested pTKlacZ. pUC sequences were removed
by digestion with SmaI, NotI and Scal prior to injection of embryos.
glIConservedTKlacZ. gIICons5'TKlacZ. 257glITKlacZ: portions of the
second intron were PCR amplified from a rat nestin genomic clone.
Amplification was performed using Vent polymerase (New England
Biolabs) for 30 cycles as follows: 94°C 30"/55 0 C 30"/72°C 60", plus a
final 8 minute extension at 720 C. PCR products were isolated using
QIAEX silicon beads (Qiagen) and cloned into the vector pCRII using
the TA cloning kit (Invitrogen). The resulting plasmids were digested
with SpeI and XhoI, and the inserts ligated into pTKlacZ cut with SpeI
and SalI. This group of plasmids was prepared for injection into
mouse embryos using SmaI, SpeI and XmnI to remove the pUC
sequences.














The nestin neuroepithelial enhancer is located near the 3'
end of the second intron
The neuroepithelial enhancer was located by subdividing the
nestin second intron. Each of three overlapping restriction fragments
was placed upstream of the herpesvirus thymidine kinase (TK)
promoter driving E. coli lacZ and tested in transient transgenic mice
(see figure 1.) All of the transgenic embryos were sacrificed at E13.5
or 14.5, ages at which we can expect to see nestin expressed in all
regions of the central nervous system. An 847 bp fragment
containing the 3' end of the second intron and the entire third exon
(NsiSal gIITKlacZ, construct D in figure 1) drove reporter expression
throughout the central nervous systems of 3 out of 5 embryos
identified as transgenic by PCR on yolk sac DNA (see figure 2a). This
ratio of lacZ-expressing embryos to total transgenic mice is
comparable to that seen with the entire 1.8 kb second intron region
(10/18, construct A in figure 1.)
In contrast, there appears to be no tissue-specific enhancer
activity in the 5' end or middle of the second intron. The 5' construct,
RgIISalStuTKlacZ (B in figure 1), gave no beta galactosidase
expression in any of 3 transgenic embryos (data not shown). The
middle fragment, RgIIBbsSpeTKlacZ (C in figure 1), drove reporter
expression in 3 out of 5 transgenic embryos. However, the strongest
staining in all embryos was outside the CNS, and the pattern of
expression was different in each embryo. Only one embryo had
staining in the CNS, which was weaker than that in the face and nose
of the same animal (see figure 3a). Another embryo has staining on
the upper snout and at the proximal end of the limbs, but none in the
CNS (figure 3b). Since the staining pattern with construct C varies so
greatly from mouse to mouse, we conclude that it does not contain
any CNS tissue-specific activity.
The 847 bp enhancer fragment, which drives CNS-specific
expression in construct D, could not be easily subdivided with
restriction enzymes. Instead, we deleted relatively short restriction
fragments from it. Removal of 83 basepairs from the upstream end
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of this 847 bp region by digestion with SpeI does not affect the
activity of the tissue-specific element: the construct SpeSal gIITKlacZ
(E in figure 1) drives CNS lacZ expression in 3 of 4 transgenic
embryos (figure 2b). The pattern of staining is not distinguishable
from construct D.
On the other hand, deletion of a 70 bp EcoRI fragment from the
middle of this 847 bp piece (deltaRIRI-NsiSal gIITKlacZ, F in figure 1)
affects the activity of the enhancer. Six of ten transgenic embyos had
staining specifically in the CNS, but only one stained the full length of
the CNS. The others had abnormal rostral or caudal limits of
expression (see arrowheads in figure 4). 4 embryos have no
expression posterior to the hindbrain, and one is lacking expression
in most of the forebrain. Notably, the tissue specificity of the
enhancer is not altered; lacZ is not found outside the CNS in any of
these embryos. It may also be noteworthy that two of these embryos
have strong expression in the forebrain and midbrain, but none in
the spinal cord (4b and 4c).
The position of the neuroepithelial element is predicted by
sequence conservation between the rat and human nestin
genes
The deletion of the 70 bp EcoRI fragment suggested that
sequences roughly in the middle of the 847 bp enhancer region are
important for activity. As discussed previously, the sequence of the
human nestin second intron was made available to us by Dr. Urban
Lendahl. While the rat and human second introns are 52% identical
overall, the area of highest homology is also located in the middle of
the 847 bp fragment. A stretch of approximately 375 bp was
identified in the rat gene with 78% identity to the human intron.
This highly conserved region was isolated by PCR and placed
upstream of the TK promoter-lacZ construct. Six of Ten transgenic
mice produced with this plasmid (gIIConsTKlacZ, G in figure 1) show
lacZ staining throughout the CNS (see figure 5). However, only three
of these six show continuous expression in the various regions of the
brain and along the length of the spinal cord. The other three express
lacZ in discrete patches in the brain and lateral stripes in the spinal
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cord; it seems that small groups of cells are lacZ positive while
neighboring groups are unstained (figure 5b,c). This patchy
expression pattern was observed in only one mouse bearing a larger
portion of the nestin enhancer, the 847 bp of construct D.
The conserved 375 bp region was further divided into two
overlapping fragments of approximately 250 bp. These were
generated by PCR and tested in transgenics. The 5' portion
(gIICons5' TKlacZ, H in figure 1) gave various ectopic expression
patterns in 4 of 10 transgenic embryos (see figure 6). Portions of the
CNS are stained in two of these animals: the spinal cord in figure 6a
and the dorsal midbrain and a portion of the spinal cord in figure 6b.
However, the second of these two embryos has much stronger
staining in the face and limbs than in the CNS. The expression pattern
is very different in each of the four embryos, so it appears that the 5'
end of the conserved region is not sufficient for tissue-specific
activity.
The 3' 257 bp portion of the conserved region (257gIITKlacZ, I
in figure 1) drove expression of lacZ in the CNS of 6 out of 8
transgenic embryos. Again, discrete patches or stripes of beta
galactosidase were seen in half of the six embryos, while the others
showed continuous expression (see figure 7). The embryo shown in
figure 7c has relatively little expression in the CNS, so the discrete
stripes of lacZ in the spinal cord are easily seen. From the rear the
brain appears negative, but the telencephalon is dotted with points
of staining. Overall, the expression pattern obtained with
257glITKlacZ is very similar to that given by the entire second
intron. The embyos shown in figures 7a and 7b appear to be lacking
expression in the area between the cerebral cortices and the
midbrain, and staining of this area is relatively weak even with the
complete second intron. This area may stain poorly because the
diencephalon is further from the surface of a whole-mounted
embryo than are the cortex, midbrain, or spinal cord. Alternatively,
additional elements may be necessary to direct expression to these
areas.
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The 257 bp CNS tissue-specific element recapitulates the
neural expression pattern of pNesPlacZ+3 introns
Additional transient transgenic mice injected with the plasmid
257gIITKlacZ were sacrificed at E9.5 or E16.5 to examine the 257 bp
element's function at early and late periods of nestin expression.
These embryos are compared here to the patterns of CNS staining
seen in pNesPlacZ+3 introns stable lines, which express lacZ in both
neural and muscle precursors.
At E9.5, expression of 257gIITKlacZ is mostly limited to the
ventral neural tube. LacZ staining is seen in ventral diencephalon,
mesencephalon, metencephalon and spinal cord. The dorsal neural
tube is stained only in the metencephalon and rostral spinal cord
(figure 8). The anterior portion of the hindbrain, surrounding the
otic vesicle, is virtually lacZ negative in these embryos. Just posterior
to the otic vesicle there is a sharp boundary where lacZ expression
begins, and this staining extends down the spinal cord beyond the
forelimb bud. The staining pattern in the CNS of E9.5 pNesPlacZ+3
introns embryos is very similar. Reporter expression is mainly
confined to the ventral neural tube posterior to the optic vesicle,
with dorsal expression first appearing in the roof plate of the
metencephalon and myelencephalon, then spreading to the dorsal
spinal cord (figure 8b, reproduced from [Zimmerman et al., 1994].)
Thus, with the possible exception of the hindbrain, 257gIlTKlacZ
reproduces the early expression pattern seen in a nestin reporter
construct with 5.8 kb of upstream sequences and 5.3 kb of intragenic
sequences.
The 257gIITKlacZ construct also appears to allow extinction of
reporter expression during neurogenesis. Figure 9 shows that
transgenic embryos at E16.5 have strong lacZ staining in the
subventricular zones surrounding the lateral ventricles of the
telencephalon (see figure 9a). It has been previously observed that
nestin expression at this age is largely limited to the ventricular and
subventricular zones of the telencephalon [Dahlstrand et al., 1995], as
is the lacZ reporter here. At higher magnification (figure 9b), strong
reporter expression is seen in the SVZ, with blue radial processes
extending across the intermediate zone (arrowhead) and a blue layer
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at the pial surface (arrow), which is probably the pial endfeet of the
radial cells [Zimmerman et al., 1994]. Very little lacZ staining is seen
in the outer layers of the cortex where the maturing neurons are
located. It appears that differentiating neurons are able to down-
regulate expression via the 257 bp element.
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Figure 1. Map of nestin second intron fragments assayed for
CNS-specific activity in transient transgenic embryos
Black bars on this map show the regions of a rat nestin genomic clone (A)
which were inserted into the plasmid pTKlacZ and tested in transient
transgenic embryos for the capacity to drive lacZ transcription in the neural
tube. Restriction fragments or PCR fragments of the rat nestin second intron
were inserted upstream of the herpesvirus thymidine kinase basal promoter
and the E. coli lacZ gene in the plasmid pTKlacZ. The resulting constructs were
injected into fertilized mouse eggs and removed from foster mothers on
embryonic day 13.5 or 14.5. Embryos were assayed for central nervous system-
specific pgalactosidase activity by X-Gal histochemistry, and for the presence
of the transgene by PCR on yolk sac DNA.
A. Second intron region of a rat nestin genomic clone. This 1832 bp
fragment produced strong CNS-specific expression in 10 out of 18 transient
transgenic embryos [Zimmerman et al., 1994]. The CNS-specific activity of this
fragment is independent of its orientation or order relative to the reporter
gene.
B. RgIISalStuTKlacZ A 585 bp BstYI-StuI fragment of nestin genomic DNA
was inserted upstream of TKlacZ in the reversed orientation, i.e. coding strand
orientation relative to lacZ is opposite to that found in the genome. No
pgalactosidase expression was found in any of three transgenic embryos.
C. RgIIBbsSpeTKlacZ A 587 bp BbsI-SpeI fragment from the middle of the
second intron was inserted in a reversed orientation upstream of TKlacZ.
Various patterns of ectopic staining were seen in three of five transient
transgenic embryos.
D. NsiSalgIITKlacZ An 847 bp NsiI-BstYI fragment including the 3' end of
the second intron and the entire third exon was inserted in the forward
orientation upstream of TKlacZ. Strong expression was seen through the full
length of the CNS in three of five transgenic embryos.
E. SpeSalgIITKlacZ Identical to construct D, except an 83 bp NsiI-SpeI
fragment was removed from the 5' end of the genomic DNA before insertion
into pTKlacZ. Expression pattern was identical to that of construct D in three of
four transgenic embryos.
F. A RI-RI NSgIITKlacZ Identical to construct D, except a 70 bp EcoRI
fragment was removed from the middle of the nestin genomic DNA and
religated. Six of ten transgenic embryos displayed expression in the brain, but
only two expressed in the spinal cord and only one had strong expression
through the length of the neuraxis.
G. gIIConsTKlacZ A 373 bp fragment of genomic DNA highly conserved
between the rat and human nestin second introns was isolated by PCR and
inserted into pTKlacZ. Six of ten transgenic embryos display CNS-specific
Pgalactosidase expression.
H. gIICons5'TKlacZ A 253 bp fragment corresponding to the 5' portion of the
region tested in construct G was isolated by PCR and inserted into pTKlacZ.
Various ectopic expression patterns, including some CNS activity, were seen in
four of ten transgenic embryos. None of the embryos had expression
selectively in the CNS.
I. 257glITKlacZ A 257 bp fragment corresponding to the 3' portion of the
region tested in construct G, and overlapping by 137 bp the region used in
construct H, was isolated by PCR. This construct produced CNS-specific
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Figure 2. The 3' end of nestin's second intron directs
reporter expression to the central nervous system
(A) Whole-mount E13.5 transient transgenic embryo produced with
the plasmid NsiSalgIITKlacZ (see figure ID). The 847 bp fragment of
nestin genomic DNA includes the downstream end of the second
intron plus the entire third exon. Strong CNS-specific staining is seen
along the entire length of the neuraxis.
(B) Whole-mount E13.5 transient transgenic mouse made with the
plasmid SpeSalgIITKlacZ (see figure lE). Strong CNS-specific staining





Figure 3. A middle portion of the second intron creates
various patterns of ectopic expression
Two whole-mount E13.5 transient transgenic embryos made with the
plasmid RgIIBbsSpeTKlacZ (see figure IC). Although weak CNS
staining is present in one embryo (A), the other two transgenic
embryos have no CNS staining (B) and data not shown.
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Figure 4. Deletion of a 70bp EcoRI fragment affects the
limits of the expression domain but not CNS-specificity
Six whole-mount E13.5 transgenic mice bearing the plasmid
ARI-RI NSgIITKlacZ (see figure 1F). Expression is specific for the CNS
in all six, but strong and complete in only one embryo (A). Other
embryos have more restricted domains of expression; the observed
anterior and posterior limits of P3galactosidase activity are marked
with arrowheads. Two embryos (B, C) have strong expression in the
forebrain and midbrain but lack all expression in the spinal cord. The
other three are weakly expressed in the brain and lacking in some
portions of the CNS.
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Figure 5. A 373 bp region highly conserved between the rat
and human nestin second introns directs expression to the
CNS
Three whole-mount E13.5 embryos made with the plasmid
glIConsTKlacZ (G in figure 1). pgalactosidase staining is seen only in
the CNS of each embryo. About half of the stained embryos display
transverse stripes of staining in the spinal cord (B) or amorphous
patches of staining in the cortical hemispheres (C).
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Figure 6. A 5' portion of the conserved region is insufficient
for CNS-specific expression
Two whole-mount E14.5 embryos produced with the plasmid
gIICons5'TKlacZ, containing the upstream 253 bp of the conserved
region (H in figure 1). Staining of portions of the CNS is sometimes
seen, as in the two embryos shown here. The embryo in (A) has
strong reporter expression in the spinal cord and hindbrain, but none
in the brain. The embryo in (B) has faint expression in the midbrain
and spinal cord, along with very strong expression in the face and
limbs. However, each of four fGal expressing transgenic embryos has
a different pattern of ectopic expression.
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Figure 7. The 3' portion of the conserved region drives
reporter expression specifically to the central nervous
system
Whole-mount E13.5 embryos bearing the plasmid 257gIITKlacZ
(construct I in figure 1). Staining is seen only in the CNS of each
mouse. In one embryo, expression is limited to a number of
transverse stripes in the spinal cord (C) and small patches in the
cerebral hemispheres (not shown).
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Figure 8. The 257 bp CNS-specific element directs correct
onset of expression in the neural tube
Whole-mount E9.5 transgenic embryos made with 257gIITKlacZ (A)
or pNesPlacZ+3 introns (B). Expression in the early CNS is similar
whether driven by 257 bp of the second intron (A) or 11.1 kb of
nestin genomic sequences containing all three introns (B). The
embryo in (B) also has staining in the somites, due to the presence of
the first intron muscle-specific element. CNS staining is seen only
from the optic vesicle to just posterior of the forelimb bud in either
embryo. In both cases, CNS expression appears first in the ventral
neural tube and discrete dorsal regions of the hindbrain. Expression
from the 257 bp element is noticeably weaker in the ventral
myelencephalon and telencephalon than in other regions.
f, forelimb bud; o, optic vesicle; v, otic vesicle; 1, telencephalon; 2,
diencephalon; 3, mesencephalon; 4, metencephalon; 5,
myelencephalon.





Figure 9. The 257 bp CNS-specific element directs
expression to zones of neuronal precursor proliferation
Coronal sections through forebrain of an E16.5 transient transgenic
embryo made with the plasmid 257gIITKlacZ. Strong lacZ staining is
seen surrounding the telencephalic ventricles in (A). An adjacent
section at higher magnification shows that the strongest expression is
in the subventricular zone, the proliferating region of cortex at this
age. The arrowhead points to fine radial processes which stain for
p3galactosidase, and the arrow indicates a band of staining along the
pial surface. These are possibly the elongated cell bodies and radial
endfeet, respectively, of radial glia.




The transgenic mouse assays presented here demonstrate that
a 257 bp fragment of the nestin second intron contains the elements
necessary for CNS-specific expression of the lacZ reporter gene. This
expression is strong in most embryos and stains all regions of the
brain and spinal cord. Analysis of transgenic mice at E9.5, during the
period of neural tube closure, shows that the reporter gene follows
the previously observed sequence of nestin activation. LacZ appears
mainly in the ventral neural tube at E9.5, and dorsally only in the
metencephalon and rostral spinal cord. Likewise, sections of older
transgenic embryos at E16.5 show that the reporter gene is
extinguished in newly postmitotic neurons, as has been shown for
the nestin gene [Dahlstrand et al., 1995]. Thus this 257 bp region
appears to contain the appropriate cis-acting sequences for the onset
and extinction of nestin expression as well as the tissue-specific
elements.
Although there is no loss of tissue-specific or developmental
regulation in narrowing down these elements from the 1832 bp
second intron region to 257 bp, some possible changes in activity are
seen. Only half of the lacZ-positive embryos generated with the 257
bp or 373 bp constructs showed continuous reporter expression
through the CNS. The other half showed discrete patches of staining
in the brain or transverse stripes of staining in the spinal cord. These
patches and stripes are possibly related to the chimerism of the
transient transgenic mouse embryos; DNA injected into the
pronucleus of a one cell embryo is thought to integrate into the
genome only after several cell divisions. Even in those animals where
lacZ expression seems continuous, some cells of the CNS are probably
derived from non-transgenic blastomeres. The diffusion of the blue
lacZ reaction product usually hides this fact. In the mice with patchy
staining patterns shown here, it may be that most of the embryo is
derived from non-transgenic cells, so the patchiness is caused by a
lower rate of transgene insertion into blastomeres. On the other
hand, the patchiness could also be caused by the failure of many
transgenic cells to express the reporter, which would suggest that the
67
smaller fragments of the nestin enhancer are less able to drive
expression.
An interesting aspect of these patches and stripes is that they
may mark clones of cells. It has been shown in the chick spinal cord
that there is little lateral movement of cells in the early ventricular
zone and that early neuronal clones form tight transverse bands
[Leber and Sanes, 1995]. This could be why expression in the spinal
cord of some transgenic mice shows transverse stripes.
It should be noted that the 257 bp tissue-specific enhancer
region was located with the help of sequence conservation. The rat
and human nestin second introns share an approximately 375 bp
region of 78% identity. Using PCR to isolate this fragment, we
simultaneously isolated the CNS-specific control region. This shortcut
may prove valuable to others seeking to locate transcriptional
regulatory elements and who have cloned genes available from more
than one species.
Finally, according to the definition quoted earlier, enhancers
are "modular arrays of elements" and the removal of one or a few
elements is not usually catastrophic to the function of the enhancer
[Hyman et al., 1988]. That seems to be the case in the deletion of the
70 bp EcoRI fragment from the 847 bp NsiSalgIITKlacZ vector. This
fragment is part of the highly conserved 257 bp region, but its
deletion does not change the tissue specificity of expression. Rather,
in most animals this deletion prevents lacZ expression from filling
the entire CNS and in some cases limits it to the brain. Any
regulatory elements contained within the 70 base pair deleted region
are not required for CNS specificity, but have effects on the strength
or stochastic likelihood of expression, especially in the posterior CNS.
The same 70 base pair region is part of the 257 bp fragment
which is sufficient for expression throughout the early CNS. However,
it is also part of the construct gIICons5'tklacZ (H in figure 1), in which
the upstream end of the highly conserved region was shown to
produce various patterns of ectopic expression (figure 6). Half of the
lacZ-expressing mice made with this construct do have expression in
the spinal cord, or midbrain and spinal cord, but all have different
strong areas of expression outside the CNS. Clearly, the region of
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overlap between this construct and the 257 bp enhancer, which
includes the 70 bp region, is not sufficient for CNS-specific
expression. However, it may contain cis-elements capable of
increasing transcription in the posterior CNS. On the other hand, that
portion of the 257 bp enhancer which lies outside the 70 bp deletion
may be sufficient to drive CNS-specific expression.
In summary, the nestin neuroepithelial regulatory elements
have been located within a 257 bp fragment of the second intron.
This piece is small enough for in vitro analysis of protein-DNA
interactions. In the next chapter we will use DNAse I footprinting to
locate potential cis-acting sequences within this 257 bp. Then, gel
shift and methylation interference assays will be performed to
examine protein binding sites in finer detail, hoping that we will be
able to recognize known transcription factor binding motifs that will
point us toward the trans-acting factors which drive nestin
expression in the CNS.
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Chapter III: Identification of cis-acting elements by in vitro
binding assays
Introduction
In the previous chapter, the region of the nestin gene driving
transcription in the CNS was pared down to 257 basepairs. It would
have been possible to continue testing fragments of this region in
transgenic mice, and then look for factors which bind those
fragments whose deletion causes a loss of enhancer function. Instead,
we turned entirely to in vitro assays at this point, partly to avoid the
effort and expense of making so many transgenic mice. This chapter
presents the results of in vitro DNA binding studies, designed to
determine how many proteins can bind to the 257 bp element, and
what the core binding motifs are. Comparison of the bound sequences
to consensus binding sites for known transcription factor families
will allow us to guess the identities of the proteins which regulate
the nestin gene.
The first step was to roughly locate the binding sites and see
how many there are. This was done by footprinting in vitro with
deoxyribonuclease I (DNAse I). DNAse I footprinting involves mixing
an end-labeled DNA probe, in this case encompassing the 257 bp
region, with proteins from a nuclear extract. We made nuclear
extracts from various parts of the rat brain at several embryonic and
early postnatal ages. Regions of the DNA probe which are bound by
proteins in vitro are protected from subsequent random digestion
with DNAse I. This region of protection is visualized on a denaturing
gel as a set of bands which are weaker in the presence of protein
extract. This assay allows the binding sites of several proteins to be
detected at once over a large region of DNA.
The next step was to break up the 257 bp region into
fragments containing only a single binding site. We therefore
synthesized short double-stranded probes containing only one DNAse
I footprint. These were again mixed in vitro with nuclear extract
protein, but instead of being digested with DNAse, the probe/protein
mixture was analyzed on a non denaturing polyacrylamide gel.
Negatively charged DNA usually moves quickly toward the positive
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pole at the bottom of the gel, but those probe molecules which are
bound by protein are slowed by the protein's bulk and different
charge density and migrate more slowly through a gel. This is called
an electrophoretic mobility shift assay (EMSA), or "gel shift" in the
vernacular. The EMSA is a more sensitive assay for DNA/protein
interaction than the DNAse I footprinting, because in the former the
bound protein must nearly saturate the probe in order to be
detected. This is not easy in extracts from tissues containing many
cell types. The gel shift assay can also show that multiple proteins
are binding a probe. However, this assay can also detect proteins
which bind DNA in a non-sequence-dependent manner, so it is
always necessary to test the specificity of the interactions detected.
The third in vitro assay in these studies uses a variation of the
gel shift. Methylation interference assays are a means of determining
which bases in a binding site most closely interact with the binding
protein. This is done by methylating the binding site to sterically
inhibit the interaction. A short end-labeled probe is first methylated
randomly at one or a few guanine or adenine bases per probe
molecule, then mixed with protein and gel shifted as above. The
retarded band (bound probe) and normally migrating band (free
probe) are cut out of the EMSA gel, and cleaved at the methylated
bases with piperidine. Comparison of the cleavage patterns of bound
and free probes by denaturing PAGE shows that cleavage at some
bases never occurs in the bound fraction. This is because methylation
of these bases inhibits protein binding. We conclude that methylation
blocks the especially close interaction of protein with these bases,
which are part of the core binding motif.
By these means we have located five DNAse I footprints in the
257 bp nestin tissue-specific element. Each of these five protein
binding sites has been further analyzed by gel shifts and/or
methylation interference to identify a potential core motif. It is our
intention to use these core sequence motifs to identify the
transcription factors which bind this region and regulate the




Nuclear extracts were prepared by the method of [Dignam et al.,
1983]. Timed pregnant Sprague-Dawley rats (Taconic) were
sacrificed by CO2 asphyxiation. Embryos were dissected in Hank's
Balanced Salt Solution (Gibco BRL) with 3.7 g/L NaHCO3 and 3.9 g/L
HEPES [pH 7.2]. Collected tissues were pelleted at 1000 rpm in a
Sorvall RT-6000 centrifuge and resuspended in five volumes buffer
A (10 mM HEPES [pH 7.9], 10 mM KC1, 1.5 mM MgCl2, 0.5 mM
dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride [PMSF], 10
gLg/mL leupeptin, 10 ptg/mL aprotinin, and 2 Cgg/mL pepstatin.) This
was incubated on ice 10 minutes during hypotonic lysis, then
triturated a few times through a 200 gL pipet tip and transferred to
a 1.5 mL eppendorf tube. This was spun 3 minutes at 2000 rpm in a
microcentrifuge, and the pellet was resuspended in 2 volumes buffer
A. The nuclei were released by 16 strokes with a teflon microfuge
tube pestle (BelArt), then pelleted for 20 minutes at 25000 g in a
Sorvall F-20 Micro rotor. The pellet was resuspended in 2 volumes
buffer C (20 mM HEPES [pH 7.9], 420 mM NaCl, 25% glycerol
[vol/vol], 1.5 mM MgC12, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF,
10 gtg/mL leupeptin, 10 gg/mL aprotinin, and 2 gg/mL pepstatin)
and homogenized with 16 strokes of a pestle as above. The contents
were mixed 30 minutes at 40 C on a rocker platform, then spun 30
minutes at 25000g in the Sorvall F-20 Micro rotor. The supernatant
was transferred to Spectrapor dialysis tubing (MWCO 12000-14000)
and dialyzed 5 hrs at 40C versus 100 mL of buffer D (20 mM HEPES
[pH 7.9], 100 mM KC1, 20% glycerol [vol/vol], 0.2 mM EDTA, 0.5 mM
DTT, 0.5 mM PMSF.) After dialysis, the material was spun 20 minutes
at 25000g as above, then aliquoted and frozen in liquid nitrogen
before storage at -80 0 C. Protein concentration was determined using
a Pierce BCA protein assay kit and BSA standards.
DNAse I footprinting:
The plasmid pCRII-5669, containing 256 bp of the nestin second
intron, was digested with HindIII or EcoRV and labeled with [a 3 2 p]-
dCTP and Klenow fragment. Unincorporated label was removed via a
sephadex G-50 spin column (5 Prime 3 Prime.) A second digestion
with EcoRV or HindIII released the single end-labeled probe, which
was separated from the vector on low-melting agarose and purified
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on an Elutip column (Schleicher & Schuell) before being ethanol
precipitated and resuspended in TE [pH 8.0].
10000 cpm of probe were mixed with 14 jigs of tissue nuclear extract
or 15 jigs of bovine serum albumin (BSA) plus 9 jLgs of poly (dI-dC)
in footprint buffer (12 mM Tris-HCl [pH 8.0], 50 mM KC1, ImM MgC12,
1 mM CaC12, 5 mM NaC1, 1 mM dithiothreitol [DTT], 5% glycerol
[vol/vol].) This reaction was incubated 30 minutes at room
temperature. One volume (50 jiL) of footprint buffer was added just
before the addition of DNAse I (RQ1 DNAse, Promega). BSA controls
received 0-0.5 jigs DNAse I, while nuclear extract samples received
0.4-0.8 jgs. Digestion proceeded at room temperature for exactly two
minutes before being stopped with an equal volume of stop buffer
(50mM EDTA, 0.2% SDS, 100lig/mL yeast tRNA.) The reaction was
extracted once in phenol and ethanol precipitated. The DNA was
resuspended in formamide loading dyes and heated 5 minutes at 900
C before analysis on a 6% acrylamide, 7 M urea sequencing gel.
Double stranded oligonucleotide probes:
Synthetic oligonucleotides were denatured and separated by
polyacrylamide gel electrophoresis (PAGE) on 8% polyacrylamide/ 7
M urea gels. Full length oligonucleotides were eluted from crushed
gel slices in 0.1% sodium dodecyl sulfate (SDS), 0.5 M ammonium
acetate, 10 mM magnesium acetate, and purified via a Sep-Pak C18
reversed-phase column (Waters). Complementary oligonucleotides
were annealed at 10 picomoles/jL in 100 mM NaC1, 10 mM Tris-HC1
[pH 8.0], 1 mM EDTA while slowly cooling from 800 C. The double
stranded probes were labelled at a single end with [cc 3 2 p]-dCTP and
Klenow fragment, adding 200mM dATP and dGTP to fill in the
HindIII overhanging end or 200mM dTTP to label the SalI overhang.
Unincorporated nucleotides were removed by a G-25 sephadex spin
column (Select-D, 5 Prime 3 Prime.) All probes were subsequently
checked by denaturing PAGE to ensure that a single labeled species
was present.
Electrophoretic Mobility Shift Assay:
Protein binding reactions were performed by combiningl0,000 cpm
of double-stranded oligonucleotide probe and 4 jigs of tissue nuclear
extract with 2.2 jgs poly(dI-dC) and 6.0 jgs BSA in binding buffer
(12% glycerol [vol/vol], 12 mM N-2-hydroxyethylpiperazine-N'-2-
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ethanesulfonic acid [HEPES] [pH 7.9], 4 mM Tris-HC1 [pH 7.9], 60 mM
KC1, 1 mM EDTA, 1mM dithiothreitol [DTT].) In competition assays, a
100- or 500-fold molar excess of unlabeled probe or unlabeled
nonspecific competitor was added. The binding reaction occurred at
room temperature (23' C) for 30 minutes or 1 hour. Binding
reactions were electrophoresed at 200 volts on a 4% 80:1
acrylamide/bis-acrylamide/2.5% glycerol gel. The gels were dried 1
hour at 800 C and visualized on a Molecular Dynamics
PhosphorImager.
Methylation Interference:
1-2x10 6 cpm of probe was methylated with 1 giL of 99+% dimethyl
sulfate (DMS) in 200 gL of 50 mM sodium cacodylate [pH 8.0] , 1 mM
EDTA. After 5 minutes at room temperature the reaction was stopped
with one-fifth volume of 1.5 M sodium acetate, 1.0 M
P-mercaptoethanol. Magnesium chloride was added to 10 mM, along
with 20 jgg of yeast tRNA before the probe was ethanol precipitated
three times. The methylated probe was resuspended in 10 mM Tris-
HCl [pH 8.0], 1 mM EDTA (TE), at about 10000 cpm/gL.
Protein binding reactions were performed by combining100,000 cpm
of methylated probe and 40 g gs of tissue nuclear extract in binding
buffer (12% glycerol [vol/vol], 12 mM N-2-hydroxyethylpiperazine-
N'-2-ethanesulfonic acid [HEPES] [pH 7.9], 4 mM Tris-HC1 [pH 7.9], 60
mM KC1, 1 mM EDTA, ImM dithiothreitol [DTT]) for 1 hour at room
temperature (23' C). Binding reactions were electrophoresed at 200
volts on a 4% 80:1 acrylamide/bis-acrylamide gel. The wet gel was
exposed to a phosphor screen (Molecular Dynamics) to locate and cut
out the bound and free probe fractions. These gel slices were covered
in 1% agarose, 0.5x Tris-Borate-EDTA buffer (TBE), and the DNA
electrophoresed into NA45 paper (Schleicher and Schuell.) Probe was
eluted from the paper at 650 C in 50 mM Tris-HC1 [pH 8.0], 1.0 M
NaCl, 10 mM EDTA. The elution was extracted once with phenol and
ethanol precipitated. The DNA was resuspended in 1.0 M piperidine
and cleaved at 900 C for 30 minutes. The piperidine was removed by
three cycles of lyophilization, then the probe was resuspended in
formamide loading dyes (98% formamide, 10 mM EDTA, .025% xylene
cyanol, .025% bromophenol blue) at about 200 cpm/gL. Equal
activities of bound and free probes were analyzed by denaturing
PAGE on a 12% acrylamide, 7 M urea sequencing gel. Labelled probe
which had been subjected to the Maxam and Gilbert G+A reaction
was run alongside as a positional marker. The dried gel was
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visualized on X-OMAT AR film (Kodak) or a Molecular Dynamics
Phosphorlmager screen.
Oligonucleotides used in Methylation Interference and
Electrophoretic Mobility Shift Assays:
Oligonucleotide probes were designed as complementary pairs with 4
bp 5' overhangs at each end. The forward sequence of each pair is
listed below; the reverse sequence is complementary to this. In
addition, a HindIII overhang (AGCT) was placed at the 5' end of each







TREp is an artificial palindromic thyroid hormone response element





DNAse I footprinting reveals five sites of protein
interaction with the 257 bp nestin neural enhancer region
Figure 10 shows the results of DNAse I footprinting assays on a
double-stranded DNA probe containing the 257 bp neural element
defined in the previous chapter. Nuclear extracts [Dignam et al.,
1983] in these experiments were prepared from midbrain,
cerebellum, spinal cord, and cerebral cortex or telencephalon of rats
at embryonic days 13, 16, 17 and 20 or postnatal day 5 (P5).
Footprinting with brain tissue extracts is challenging because of the
variety of cell types present in each tissue. Complete protection of
binding sites from DNAse I digestion requires saturation of the probe
with binding protein, which can be difficult to achieve with purified
protein. However, the protections obtained with brain extracts are
strong enough to map footprinted regions and roughly estimate the
tissue and age distribution of binding activities.
Labeling the forward strand of the DNA probe leads to the
footprints shown in figures 10a and b. A total of five regions are
protected from DNAseI digestion in various extracts, but all five
protections are not seen in any single extract. These five regions are
diagrammed at the right of the figures with their approximate
endpoints marked. The base number listed for each endpoint refers
to its position in a nestin genomic clone, not its position relative to
the transcriptional start site (at 2473 in the genomic clone). Positions
of enhanced DNAseI digestion in the presence of protein, called
hypersensitive sites, are found adjacent to the protected regions
(footprints) numbers 2 and 5.
The same five footprints are found again when the DNA probe
is labeled on the reverse strand (figure 10c and d). The endpoints of
the protected regions are generally not the same as on the forward
strand, but the protected regions roughly correspond on the two
strands (see figure 11). Each protected region on the forward strand
overlaps one on the reverse strand, so the five pairs of protections on
opposite strands have been named footprints 1-5.
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None of the five footprints is detectable in every age and tissue
from which nuclear extracts were prepared. In these and other
experiments not shown, footprints 1 and 4 were most generally
occupied. These two sites were protected by most extracts from the
four brain regions taken at ages from E13 to P5. Footprint number 5
was almost as widespread, but was missing from some midbrain and
spinal cord extracts which protected footprints 1 and 4. By contrast,
footprints 2 and 3 are detectable in only a few tissues. Footprint 2 is
found only in the midbrain, spinal cord, and midbrain at E16, and
never in cortex. It is also found in these tissues, but not cortex, at P5
(data not shown.) Footprint 3 seems to be the most restricted of the
five. It is detectable only in cerebellum and perhaps spinal cord at
E16 (figure 10a and c) and in P5 cerebellum (data not shown.) It
appears that the transcriptional control element driving nestin
expression in all regions of the CNS may interact with some
transcription factors which are active only in limited areas of it.
Electrophoretic Mobility Shift Assays show the numbers
and tissue distributions of factors which bind the nestin
neural enhancer
DNAse I footprinting indicated five areas of the 257 bp CNS-
specific element which are bound by nuclear proteins, but suggested
that these factors may not be active in all regions of the brain. The
EMSA or gel shift assay was used to test this idea. Gel shifts are a
much more sensitive measure of DNA binding activity than
footprinting assays, because the latter requires near-saturation of
the DNA binding site by protein. The gel shift assay, in contrast, can
detect protein binding on just a few molecules of labeled probe. In
addition, proteins in the EMSA may retard migration of the DNA
probe to varying degrees depending on their bulk and charge
density. This generally produces separate bands for each binding
protein and each multiprotein complex, allowing an estimate to be
made of the number of proteins capable of binding a given probe.
Gel shifts on a double-stranded oligonucleotide containing
42 bp of nestin sequence surrounding footprinted region 1 (probe
Ftptl, see figure 17 for probe sequences) confirms that binding
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activity for this probe is widespread in the developing CNS (figure
12). Two prominent bands are seen in every CNS tissue extract
tested, whether from embryonic (E13, E16) or postnatal (P5) rats.
Three weaker and faster migrating bands are present in E13
telencephalon, and in a cortical extract from E17, but are absent at
P5. Interestingly, the a similar EMSA with the footprint 4 region
(Ftpt4) yields almost identical results (data not shown). The similar
binding patterns for these two probes may be explained by sequence
homology (see figure 17). Both DNAse I protected regions include 8
basepairs matching (at 7 of 8 bases) the "octamer" consensus binding
site for the Pitl-Oct-Unc86 (POU) family of transcription factors. In
chapter IV it will be determined whether POU proteins can bind to
footprinted regions 1 and 4 of the nestin second intron.
The last three lanes of figure 12 demonstrate that the DNA
binding activities detected in the Ftptl EMSA recognize this probe in
a sequence-specific manner. The five strongly shifted bands
produced on this probe by E17 cortical extract are displaced by a
100-fold excess of the same unlabeled probe. However, a 100-fold
excess of a probe unrelated in sequence does not compete for binding
of these proteins. Therefore these binding activities do not recognize
all DNA, but require some particular sequence present in the Ftptl
probe.
Gel shift assays on the Ftpt5 probe show that binding activity
specific to footprint 5 is found in most extracts. In figure 13, two
prominent bands are present in the cortex at E17 or P5
(arrowheads), and to a much smaller degree in the E16 cortical
extract. Only the faster-migrating of these two complexes is present
in E16 or P5 midbrain, cerebellum and spinal cord. A much weaker
band of slightly higher mobility is present in all but the cortical
extracts. Both bands of the E17 cortical doublet bind specifically to
the footprint 5 probe and are not competed away by heterologous
DNA. It therefore appears that footprint 5 is strongly bound by one
protein in most regions of the brain, but an additional binding
activity is found only in the cerebral cortex.
In contrast, binding activity for the footprint 2 and 3 probes is
much stronger in CNS regions other than the cortex. Figure 14 shows
79
gel shifts on the Ftpt2 probe, which bears 40 bp of nestin sequence
including footprint number 2. In E16 midbrain, cerebellum, or spinal
cord two strong bands are seen, the stronger of which is not present
in E16 cortex. E16 cortex has instead a weak band which migrates
slightly slower (grey arrowhead in figure 14). The quickly-migrating
band detected in all extracts at E16 is absent from all but the
cerebellum at P5; the slower-migrating band is strongest in
cerebellum and absent from P5 cortex. In summary, the Ftpt2 probe
is bound by: an activity specific to the caudal CNS, that is midbrain,
cerebellum and spinal cord; another which is present in all four
extracts at E16; and a third which may be specific to the E16 cortex.
Similarly, a probe containing the sequence of footprint 3 is
much more strongly bound by extracts from cerebellum or spinal
cord than by more rostral tissue extracts (see figure 15). Two strong
complexes are seen in most extracts (arrowheads). The faster-
running complex is present in all four brain regions at E16 but
restricted to cerebellum at P5. The slower-running complex is again
strongest in cerebellum and spinal cord, but does appear to be
present in cortex at both ages. In between these two complexes are
two sets of bands which appear to be cortex-specific. Therefore the
distribution of footprint 3 binding activity is not strictly limited to
cerebellum and spinal cord, as was suggested in DNAseI footprinting
experiments. However, both footprint 2 and footprint 3 regions are
more strongly bound in cerebellum and spinal cord.
Methylation Interference assays identify the core binding
sequences of the proteins interacting with the nestin
enhancer
The DNAse I footprinting and gel shift assays described above
show that several proteins can bind in vitro to each of five
footprinted regions of the nestin neuroepithelial enhancer. Efforts to
identify these proteins begin with more precise description of the
DNA sequences to which they bind. Comparison of these sequences
with known cis-acting sequences may point to a few transcription
factor families as possible regulators of nestin.
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Sites on DNA which closely interact with proteins can be
mapped by the methylation interference assay. This assay was
performed on the same double-stranded oligonucleotide probes used
in gel shift assays, following their modification with dimethylsulfate
(DMS). Figure 16 shows the results of methylation interference
assays on probes corresponding to each of the five footprinted
regions of the nestin CNS enhancer. For reference, a typical EMSA
performed with the same probe and nuclear extract is shown
alongside the methylation interference results. Following a large-
scale gel shift of methylated DNA, the probes are isolated and
cleaved with piperidine prior to PAGE analysis. Comparison of the
probes bound by protein (lanes marked Bound or Bd) with
uncomplexed probe (lanes marked Free) indicates at which guanine
or adenine residues methylation can sterically inhibit protein
binding.
Protein interactions with the bottom strand of the footprint 1
region are shown in figure 16a. Nuclear proteins from the E17 rat
cortex produce several complexes with this probe, as shown in a
typical gel shift (inset). The lanes of the methylation interference gel
correspond to the bands marked Bdl, Bd2, Bd3 and Free in the gel
shift assay. Comparison of piperidine cleavage patterns between the
three bound lanes and the free probe show that six adenines are
relatively uncleaved in bound DNA (arrowheads, fig. 16a).
Methylation of these same six adenines inhibits formation of all three
bound complexes to approximately the same degree, even though the
Bd3 complex can be seen in the gel shift lane to actually be composed
of three discretely shifted bands. It appears that the binding site
defined by methylation interference of the Ftptl probe is involved in
formation of at least four different protein-DNA complexes. These
complexes may represent different binding proteins, or a variety of
multi-protein combinations, or could be produced by subtle
differences in charge of a single binding protein.
The location of the methylation interference sites of these
complexes relative to the footprinted area is summarized in figure
17a. The adenine/thymine-rich sequence which includes the six
blocked adenines overlaps a seven of eight base-pair homology to
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the well known octamer sequence 5'-ATTTGCAT-3', the consensus
binding site of the Pit-l/Oct/Unc-86 (POU) transcription factor
family [Wirth et al., 1987] (see figure 17a).
Methylation interference on an oligonucleotide probe
corresponding to footprint 4 tells a similar story (figures 16d and
17d). Methylation of any of three adenines on the bottom strand
inhibits formation of four isolated protein-DNA complexes. As with
footprint 1, the fastest-migrating group is actually three different
shifted bands too close to be separated in the methylation
interference assay. The three blocked adenines on the Ftpt4 probe
are again part of an A/T-rich sequence overlapping a seven-of-eight
base pair homology to the octamer sequence. Methylation
interference was not performed on the top strand of this probe. The
two octamer-like sequences differ somewhat: 5'-ATTTGCTT-3' in
Ftptl versus 5'-ATTAGCAT-3' in Ftpt4. The similarity of the
complexes seen in EMSAs and the methylation interference sites of
these two probes suggest that the two sites are bound by the same
protein or group of proteins. The presence of octamer-like motifs
adds the possibility that footprints 1 and 4 are occupied by POU
family members.
Methylation interference demonstrates strong similarities
between footprints 2 and 3. In EMSAs, each oligonucleotide probe
shows a major complex most abundant in spinal cord and cerebellum,
and relatively lacking in cortex and midbrain. Methylation
interference of this major complex with E16 spinal cord nuclear
extract points out the similarity in the binding sites. Binding of the
Ftpt2 probe is blocked by methylation of two adjacent guanines on
the top strand, and three of four nearby guanines on the bottom
strand (figures 16b and 17b). The sequence encompassing the five
blocked guanines reads (along the top strand) 5'-TCCCCTGGGAA-3'.
This is a close match to a sequence occurring within footprint 3,
reading along the top strand: 5'-TCCCCTGAGGA-3'. Methylation
interference was performed on the bottom strand of the Ftpt3
oligonucleotide probe, and revealed that this sequence is part of the
protein binding site (figures 16c and 17c). Methylation at any of the
four guanines complementary to the shared top strand sequence
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inhibits protein binding to the Ftpt3 probe. In addition, three
guanines further 3' along the bottom strand are also required for
protein binding. The similar methylation interference sites on the
two probes suggest that footprints 2 and 3 are recognized by the
same or related proteins.
The conclusion that related proteins bind footprints 2 and 3 in
vitro is further supported by gel shift assays using double-stranded
oligonucleotide competitors. Figure 18 shows that binding of nuclear
proteins from E16 rat spinal cord to a labeled Ftpt3 probe is
completely inhibited by a five hundred-fold molar excess of
unlabeled probe for either Ftpt3 or Ftpt2. A similar quantity of an
unrelated probe, in this case an artificial palindromic thyroid
hormone response element (TREp), does not compete away the
binding protein. The same cross-competition is observed with a
labeled Ftpt2 probe and excess unlabeled Ftpt3 probe. This
competition assay strongly suggests that the two probes bind the
same protein. It must be noted that the two oligonucleotide probes
used here have fourteen base pairs of genomic sequence in common,
in addition to homology between them described above. However,
methylation interference is observed at only the last base of these
fourteen (see figure 17c). It is more likely that the binding site of the
related proteins is the region of sequence homology in the middle of
each probe which is blocked by methylation. Notably, this sequence
homology is similar to the consensus motif reported by [Imagawa et
al., 1987]as the binding site of the transcription factor AP-2.
Finally, methylation interference of the Ftpt5 probe reveals a
third type of binding site (figures 16e and 17e). In the gel shift
assay, two strong protein-DNA complexes migrate very close
together, and a third slower-migrating complex (Bdl) is sometimes
detected. On the top strand, all three complexes are inhibited by
methylation at either of two adjacent guanines. A nearby guanine is
the only detectable site of interaction on the opposite strand with the
two more abundant proteins (Bd2 and Bd3). The sequence
comprising these three methylation interference sites on Ftpt5 has
homologies to a number of transcription factor binding sites. The
eight base pair sequence 5'-TGAGGTCA-3' is identical to a site in the
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MHC class I promoter which binds a tri-iodothyronine receptor/9-
cis-retinoic acid receptor beta heterodimer (T3R/RXRP) [Marks et al.,
1992]. However, this site is an atypical one, as most T3R/RXRP
binding sites are palindromes or direct repeats spaced by 4
nucleotides [Umesono et al., 1991]. The same eight bases are also
similar to the consensus cAMP response element (CRE), the binding
site of CRE-binding protein (CREB). Since CREB binds as a dimer to
inverted repeat sequences, it may be relevant that the methylation
interference sites of footprint 5 are at the center of a five base pair
inverted repeat: 5'-GATGAGGTCATC-3'. Another trans-acting activity
which binds similar inverted repeats is AP-1, a dimer formed by fos,
jun, or related proteins. All of these proteins may be candidates for
binding to this region of the nestin CNS enhancer.
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Figure 10. DNAseI footprinting assays on the 257 bp nestin
CNS-specific element
DNAse I footprinting on a HindIII-XbaI fragment of pCRII-257 which
contains the entire 257 bp CNS-specific element of the rat nestin
second intron. In each lane, end-labeled DNA was mixed with 14 jigs
of rat brain nuclear extracts, or 14 g gs of bovine serum albumin
prior to digestion with DNAse I for exactly 2 minutes. Tissues were
collected on embryonic days E13, E16, or E17 or postnatal day P5.
(A) Footprinting on the forward strand of the DNA probe. Five
regions of protection are marked by black boxes at the right of the
figure. The five footprints are not all visible in any one extract. In
this experiment, footprint 2 is apparent only in E16 midbrain,
cerebellum, and spinal cord; footprint 3 is visible only in E16
cerebellum. Approximate endpoints of footprints are indicated with
the corresponding base number in a nestin genomic clone. The
transcriptional start site in this genomic clone is at 2473. Sites of
greater digestion in the presence of some tissue extracts
(hypersensitive sites) are marked with an asterisk.
(B) A portion of another footprinting experiment on the forward
strand, showing footprint 5 more clearly.
(C) Footprinting on the reverse strand of the same DNA fragment.
Four footprinted regions are detected and numbered 2-5 to
correspond to the footprints on the forward strand. Footprints 2 and
3 are seen in the same tissues as on the forward strand.
(D) A portion of another footprinting experiment on the reversed
probe shows that footprint 1 can also be detected on this strand.
BSA, bovine serum albumin; Tel, telencephalon nuclear extract; Ctx,
cortex; Mid, midbrain; Cb, cerebellum; SpC, spinal cord; G+A, Maxam-
Gilbert guanine+adenine sequencing reaction performed on the same
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Figure 11. Summary of protected regions detected by
DNAse I footprinting
Sequence of both strands of the 257 base pair CNS-specific element
of the rat nestin second intron. Footprinted regions are marked by
stippled boxes, and hypersensitive sites by asterisks. The protected
regions detected on the forward strand roughly line up with those on
the reverse strand, so aligned footprints on opposite strands are
given a single number from one to five. The bases are numbered
relative to the genomic clone, as in figure 11.
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DNAsel Footprinting Reveals Five Protein-
Binding Sites in the Nestin Enhancer
Footprint 15669
GGTCTGAAAA GGATTTGGAG AAGGGGAGCT GAAT*CATTT G TTTTGTCT
CCAGACTTTT CCTAAACCTC TTCC CTCGA CTTAAGTAAA CGAA~CAGA
Footprint 25719
GTTACCAGCT CTGGGGGCAG AGAGAcXCC ATCCCCTGGG AACAG4CTGA
CAATGGTCGA GACCCCCGTC TCTCTCTCLG TAGGGGACCC TTGTC GACT
5769 Footprint 3
GCTTCCCAC TTCCCCTGAG GAGCC TCCC TTCTTAGGCC CTCCAGATGG
TTAAGGGTG AAGGGGACTC CTCGGGAGGG AAGAATCCGG GAGGTCTACC
5819 Footprint 4 * **
TAGTGTGGAC AAAGGCAAT AATTAGCAG AGAATCGGCC TCCCTCCCAG
ATCACACCTG T TTCCGTTA TTAATCGTAC TCTTAG CGG AGGGAGGC
5869
Footprint 5
AG TGAGGT CATCGGCCTT GGCCTTGGGT GGGGAGGCGG AGACTGATCT




* = DNAseI hypersensitive site
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Figure 12. The footprint 1 region is bound in vitro by
several proteins from various portions of the developing
CNS
Electrophoretic mobility shift assays (EMSA) performed with a
double-stranded oligonucleotide probe containing the footprint 1
region of the rat nestin second intron (see figure 17 for sequence of
probe Ftptl). The labeled probe was mixed with four gLgs of nuclear
extract from each tissue tested. DNA probes which are bound by
proteins are retarded in mobility and are thus closer to the top of the
gel (left of figure) than unbound probes, which in lanes 1-10 have
been run just off the bottom of the gel (at the right of the figure.)
Sequence specificity of binding is demonstrated in lanes 11-13. The
complexes formed by E17 cortical extract on the Ftpt 1 probe are
displaced by a 100-fold molar excess of the unlabeled Ftptl probe
(lane 12), but not by the unrelated probe TREp (lane 13) which
contains an artificial palindromic thyroid hormone response element.
Tel, telencephalon nuclear extract; Ctx, cortex; Mid, midbrain; Cb,











Figure 13. The footprint 5 region is bound by a small
number of activities, one of which is specific to the cortex
EMSA performed with the Ftpt5 probe, containing 42 bp of nestin
second intron sequence encompassing footprint number 5. The free
probe has been run just off the bottom of the gel in order to better
separate the shifted bands. Two strong bands (arrowheads) are seen
in P5 cortex or E17 cortex (lanes 5 and 9). Only one of these is
present, along with a weaker band of greater mobility, in midbrain,
cerebellum and spinal cord. Lanes 9-11 show that the two strong
bands produced by E17 cortical extract are sequence-specific, as they
are displaced by 100-fold excess of unlabeled Ftpt5 probe but not by
a similar quantity of cold Ftpt4.
Tel, telencephalon nuclear extract; Ctx, cortex; Mid, midbrain; Cb,
cerebellum; SpC, spinal cord
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Figure 14. The footprint 2 region is recognized by different
sets of proteins in the cortex than in the rest of the CNS
EMSA performed with the Ftpt2 probe (see figure 17). The E16
midbrain, cerebellum, and spinal cord extracts show two prominent
binding activities, the slower-migrating of which (black arrowhead)
is not present in cortex either at E16 or P5. The faster-migrating
band is virtually absent from all but cerebellum at P5. E16 cortex
has a second weak and slow-migrating band (grey arrowhead) which
may not be present in the rest of the CNS extracts. Lanes 9-11
demonstrate the sequence-specificity of the two binding activities
present in E16 spinal cord, by competition with a 500-fold molar
excess of the cold probe (Ftpt2) or nonspecific oligo (TREp).
Tel, telencephalon nuclear extract; Ctx, cortex; Mid, midbrain; Cb,
cerebellum; SpC, spinal cord; Free, unbound probe
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Figure 15. The footprint 3 region is most strongly bound by
extracts of cerebellum and spinal cord
EMSA on the Ftpt3 probe shows two complexes (arrowheads) which
are present in all extracts tested. The lower band of this pair is much
stronger at E16 than at P5, but occurs in all four brain regions at
both ages. The upper band is very strong only in E16 cerebellum and
spinal cord, and in P5 cerebellum. It is weak but present in cortex
and midbrain at both ages. The sequence-specificity of these bands
in established in figure 18.
Tel, telencephalon nuclear extract; Ctx, cortex; Mid, midbrain; Cb,
cerebellum; SpC, spinal cord; Free, unbound probe
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Figure 16. Methylation interference assays show multiple
complexes bind the same core recognition sequences
The five double-stranded oligonucleotide probes (Ftptl-Ftpt5, see
figure 17) originally used in EMSA assays were partially methylated
with dimethylsulfate prior to being gel shifted with 40 jigs of nuclear
extract. Bound protein-DNA complexes and free probe were isolated
from a nondenaturing gel, then cleaved by piperidine at methylated
bases. Comparison of cleavage sites between bound and free DNA
indicates bases at which methylation sterically inhibits protein
binding.
At the left of each figure is a typical EMSA performed with 4 jigs of
nuclear extract. This illustrates the relative migration rates of the
complexes isolated in methylation interference assays. Complexes
which run too closely to be individually isolated are labeled together.
Bd, protein-DNA complex; Free, unbound DNA; G+A, Maxam-Gilbert
sequencing reaction for purines. The sequence of the probe appears
next to this lane.
Arrowheads indicate positions at which methylation interferes with
protein binding. Results are summarized in figure 17.
(A) Methylation interference on the reverse strand of the probe
Ftptl, using E17 cortical extract. Methylation interference is
observed at six adenines.
(B) Methylation interference on both strands of Ftpt2, with E16
spinal cord extract. Interference occurs at two guanines on each
strand.
(C) Methylation interference on the bottom strand of Ftpt3, using
E16 spinal cord extract. The faster-running bound complex seen in
the EMSA was not present in the scaled-up reaction for methylation
interference. In the slower-migrating complex, interference occurs at
seven guanines.
(D) Methylation interference on the bottom strand of Ftpt4,
performed with E17 cortical extract, blocks protein binding to three
adenines. Note that the same three adenines block at least four
different complexes, as "Bd4" is actually three separate bands.
(E) Methylation interference on both strands of Ftpt5 with E17
cortical extract. Interference with binding occurs at a single guanine
on the reverse strand and at two guanines on the forward strand.
This pattern is the same for each isolated complex. The apparent
interference in the Bdl lane at two guanines nearer the bottom of
the figure has not been reproducible.
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Figure 17. Summary of methylation interference patterns.
Sequences of the double-stranded oligonucleotides used for EMSA
and methylation interference assays are shown. Each probe contains
40-42 bp of nestin second intron sequence, with added HindIII and
Sall 5' overhangs to allow end-labeling with Klenow.
Over- or under- lining shows bases protected from DNAseI in
footprinting assays on the 257 bp enhancer fragment (see figure 10).
v or ^ indicates site of methylation interference (see figure 16).
"ATTTGCaT" or similar short sequence under the probe sequence
indicates a region homologous to the recognition site of a known
transcription factor, or points out the homology between footprint 2
and footprint 3. Capital letters indicate identity, small letters are a
mismatch.
(A) Ftptl probe. Three complexes bind a site overlapping with a
seven-of-eight base pair match to the octamer recognition site of POU
proteins.
(B) Ftpt2 probe. One complex binds a site very similar between
Ftpt2 and Ftpt3. This sequence is also homologous to the recognition
motif for AP--2 as reported by [Imagawa et al., 1987].
(C) Ftpt3 probe. One complex binds an extended site, part of which
is similar to Ftpt2.
(D) Ftpt4 probe. At least four complexes bind three adenines
which overlap another seven-of-eight base pair match to the octamer
motif.
(E) Ftpt5 probe. Three complexes bind a site with a number of
interesting homologies. First, eight bases are identical to a binding
site for thyroid hormone receptor/retinoid X receptor P found in the
class I Major Histocompatibility Complex promoter [Marks et al.,
1992]. Second, seven of these eight bases are identical to the
consensus cyclic AMP response element, and six of eight are identical
to the consensus AP-1 site [Meyer and Habener, 1993].
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Summary: Methylation Interference Patterns and




































Figure 18. Ftpt2 and Ftpt3 probes can compete with one
another for binding of the same or similar proteins.
EMSA with cross-competition between Ftpt2 and Ftpt3 using E16
spinal cord nuclear extract. Two complexes are formed by E16 SpC
extract on both probes, and the mobilities and strengths of these
complexes are very similar. Each complex binds in a sequence-
specific manner, as excess unlabeled probe displaces it but not excess
nonspecific oligonucleotide (TREp). In addition, each complex is also
disrupted by excess probe for the neighboring footprinted region. All
unlabeled competitors are used at 500-fold molar excess over
labeled probe.
This experiment indicates that the two probes share a sequence
recognized by the two proteins. As noted in figure 17, these two
probes are homologous to one another at a sequence which is the
core binding site as determined by methylation interference.
]However, footprints 2 and 3 are so closely spaced that the sequences
of these two probes also overlap. A 14 bp stretch is part of both
probes. So while these two probes definitely bind the same protein








The experiments described in this chapter have shown that the
257 base pair fragment of the nestin second intron which functions
in vivo as a CNS-specific transcriptional regulatory sequence is
specifically bound by nuclear proteins in vitro. Protein binding
assays performed in vitro are thus a convenient method to identify
transcription factors which could be responsible for the in vivo
function of the CNS regulatory element.
The nestin CNS regulatory element was first analyzed in vitro
by DNAse I footprinting. This method revealed 5 areas of nuclear
protein binding within the 257 base pair fragment, although some of
these areas were not detectably bound in all tissues or all ages
tested. The proteins which bind these footprints cannot be said on
this basis to be absent from some tissues, since the footprinting assay
requires near-saturation of the available DNA by bound proteins.
This may be difficult to achieve when tissue extracts are used, as in
the experiments reported here, due to the presence of multiple cell
types. Generally speaking, the five footprinted areas fall into two
categories. Footprints 1, 4, and 5 are present in the cortex as well as
the other CNS regions tested (midbrain, cerebellum, and spinal cord)
at almost all of the developmental ages examined. By contrast,
protection of footprints 2 and 3 was not seen in cortex, and was
strongest in spinal cord and cerebellum. Since terminal
differentiation of neurons in the spinal cord precedes that in cortex,
which precedes that in cerebellum, there is no correlation of
footprint 2 and 3 binding activities with developmental progression.
Rather, the protection of these two areas is stronger in more caudal
regions of the CNS.
When each of the five footprinted areas is isolated on a short
double-stranded probe, named Ftptl-5, specific protein binding to
each area is detectable by the gel shift assay. Gel shift assays show
that multiple protein activities interact with each of these five
binding sites, and the tissue distributions of these are much more
complex than indicated by DNAse I footprinting. One important point
about the tissue distributions is that nuclear extracts which fail to
protect a given binding site from DNAse I are usually not completely
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lacking in binding activity for that site. For example, factors which
bind footprints 2 and 3 are present in embryonic cortex. However,
the low abundance of these factors in cortex relative to spinal cord as
measured by the gel shift assay probably explains why these sites
are not footprinted by cortical extracts.
The presence of multiple binding activities in gel shift assays
on any of the five probes also complicates the picture of nestin
transcriptional regulation. As discussed previously, the multiple
bands could be different proteins, or multiple bands could be
generated by a single protein having a range of phosphorylation
states or associated molecules. In addition, in nuclear extracts
prepared from whole tissues, different binding activities may be
contributed by different cell types. Another possible explanation for
the wealth of binding activities detected by gel shift assays may be
the lack of sequence context normally provided by the flanking
regions and other binding sites. This could allow the formation of
complexes which would ordinarily be incompatible with the complex
of factors binding the enhancer.
To demonstrate that the multiple complexes detected on a
given gel shift probe interact with the same DNA site, methylation
interference assays were performed. It was determined that any
methylated base found to block formation of one protein-DNA
complex also blocked the formation of every other complex which
could be isolated with that probe. For example, at least four
separable complexes with the Ftpt4 probe interact with the same set
of three adenine bases on one DNA strand (figure 16d). In addition,
methylation interference studies suggest that the complexes detected
on short probes are the same as those detected by DNAse I
footprinting on the 257 base pair enhancer, since all binding sites
blocked by methylation fall within the limits of a previously detected
footprint (see figure 17).
Finally, the methylation interference patterns of the various
binding proteins provide clues to the identity of these factors.
Comparison of the mapped sequences with a database of
transcription factor binding sites has identified homologies to several
well-known DNA motifs (figure 17). The two probes Ftptl and Ftpt4
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produce similar gel shift patterns with CNS nuclear extracts, and both
contain homologies to the canonical octamer binding site of POU
transcription factors. The POU genes form a diverse superfamily of
proteins whose roles in neural development will be discussed in
detail in the next chapter.
Two other probes, Ftpt2 and Ftpt3, also show remarkably
congruent gel shift patterns and each probe competes with the other
for protein binding. Methylation interference studies point to a
region of sequence homology between the two probes, which is
strongly reminiscent of the consensus binding site for the dimeric
transcription factor AP-2. Unfortunately, this does not limit the
candidate binding factors for footprints 2 and 3 to a single protein.
The AP-2 family contains at least three genes designated AP-2a,
AP-2p, and AP-2.2 [Chazaud et al., 1996; Moser et al., 1995; Williams
et al., 1988], and the first described member is alternatively spliced
into four mRNAs with different tissue distributions [Meier et al.,
1995].
Binding sequence homologies also suggest a number of proteins
which may produce footprint 5. Methylation interference shows that
only a very small area of this long footprint is in close contact with
the binding factor. The sequence of this small area has homology to
previously identified binding motifs for nuclear hormone receptors,
CRE-binding proteins, or AP-1 factors. Furthermore, each of these
three groups is composed of a number of molecules. The cAMP
response element binding proteins have at least three members:
CREB, CREM, and ATF-1 [reviewed by Vallejo, 1994]. The binding
activity called AP-1 can bind to the same inverted repeat sequence
as the CREBs, and AP-1 is a dimer composed of c-fos, c-jun, or any of
their numerous relatives. Finally, the nuclear hormone receptors are
a large superfamily. The binding sites of these dimeric factors are
typically direct or inverted repeats of the half-site 5'-AGGTCA-3'.
However, some orphan receptors within this family, such as NGFI-
B/nur77 or FTZ-F1 have been found to bind as monomers to a single
half-site [Ueda et al., 1992; Wilson et al., 1992].
So while methylation interference studies have focused our
attention on a few short sequences within nestin's CNS-specific
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element, the homology of these sequences to known cis-acting
elements does not point to a small number of trans-acting factors. In
fact, we may question whether the discovery of these consensus
motifs identifies the possible binding proteins at all. This is because
the similarity of a sequence to the consensus binding site for a given
transcription factor does not necessarily predict how well that factor
will bind the sequence. Most transcription factors will bind a range of
sequences in various genes which can deviate substantially from the
consensus binding site.
The POU proteins, some of which may interact with the nestin
CNS element, provide a good example of the range of permissible
binding sequences for transcription factors. The ubiquitously
expressed POU protein Oct-1 binds strongly to the consensus binding
site for this family, the octamer motif 5'-ATGCAAAT-3' [Singh et al.,
1986]. It also binds with lower affinity to the the sequence 5'-
TAATGARAT-3', where R is any purine [Baumruker et al., 1988]. The
octamer sequence can be viewed as separate binding sites for the
two DNA-binding domains of Oct-l: The 3' AAAT sequence is bound
by the homeodomain, while the POU-specific domain interacts with
the 5' ATGC sequence [Kristie and Sharp, 1990; Verrijzer et al., 1990].
Several brain-specific POU proteins also appear to have binding
sites composed of two parts. The consensus sites for these proteins
resemble a canonical octamer in which the half which binds the POU-
specific domain is reversed, and the spacing between the two halves
may vary. The consensus binding site for Brn-2 is
5'-CATn(T/A)AAT-3', where n represents zero, two, or three bases of
any sequence [Li et al., 1993]. A distant relative, Brn-3.0, binds the
same consensus site as Brn-2 but the spacing (n) must be 3 bases [Li
et al., 1993]. Brn-3.0 binds poorly to the canonical octamer sequence.
A third distant relation, Brn-5/Emb, binds similar sites with the
consensus sequence 5'-GCATnTAAT-3' where n is 2 or 3 bases; it also
binds strongly to the octamer-like sequence 5'-ATATGATAAT-3'
[Andersen et al., 1993].
This degenerate set of possible binding sites for POU proteins
makes it harder to argue that members of this family must bind the
nestin second intron element, but does not rule it out. The consensus
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binding sites reported here for brain-specific POUs are A/T-rich
sequences different from the octamer-like sequences found in
footprints 1 and 4. However, the methylation interference patterns
found with these two probes point to A/T-rich sequences which
overlap the 5' ends of the two octamer-like sequences. So these
binding sites may be described as related to the octamer, and related
to the A/T-rich consensus sites for several brain-specific POUs. For
this reason, the work in the next chapter will address the question of
whether brain-specific POU proteins bind in vitro to footprints 1
and 4.
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Chapter IV: Identification of transcription factors which
recognize the CNS-specific element in vitro
Introduction
The experiments of the previous chapter identified five
sequences in the 257 bp nestin neuroepithelial enhancer which are
bound by proteins in vitro. Comparison of these sequences to the
consensus recognition motifs of known transcription factor families
suggests that the enhancer-binding proteins may belong to three
groups: POU proteins, AP-2-like proteins, and a yet unknown group
which could be the nuclear hormone receptor family, the CREB
family, or the AP-1 family. Members of each of these groups have
roles in adult neuronal function, but a few of the POU proteins are
especially interesting for their actions in neuronal development. This
chapter explores whether the expression of nestin is regulated by the
class III POU proteins, which are present in the early neural tube
and some of which have been shown to have roles in neural fate
determination.
The nestin neuroepithelial enhancer contains two sites related
to the octamer binding motif (5'-ATGCAAAT-3'), which is the
canonical binding site for most members of the POU transcription
factor family. This large group of homeobox-containing genes was
initially identified by the discovery of the factors Pit-1 [Bodner et al.,
1988; Ingraham et al., 1988], Oct-1 [Sturm et al., 1988], Oct-2 [Clerc
et al., 1988; Ko et al., 1988; Muller et al., 1988; Scheidereit et al.,
1988], and the Caenorhabditis elegans gene unc-86 [Finney et al.,
1988]. These genes are now grouped into six classes (POU I-POU VI)
based on amino acid sequence homologies within the highly
conserved POU-specific (POUs) and POU-homeodomain (POUhd)
regions [Wegner et al., 1993].
While some POU genes, such as Oct-1, are expressed in virtually
all cells [Sturm et al., 1988], most members of this family are tissue-
specific. The tissue-specific POU proteins are often critical at late
stages in the formation of the cells in which they are found. For
example, Pit-1 regulates proliferation and/or survival of three
anterior pituitary cell types [reviewed in Andersen and Rosenfeld,
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1995]. Oct-2 is necessary for terminal differentiation of B-cells
[Corcoran et al., 1993] and unc-86 is required to specify sensory
neurons in C. elegans [Finney and Ruvkun, 1990].
A number of these tissue-specific POU proteins are expressed
only in the brain. This distinguishes the POU family from the classical
homeobox genes; no Hox gene transcripts are found in the CNS
anterior to the hindbrain. Brain-specific POU genes include the entire
class III family, comprising Brain-i (Brn-1), Brn-2, Brn-4, and Tst-
1/Oct-6/SCIP [Hara et al., 1992; He et al., 1989; Le Moine and Young,
1992; Mathis et al., 1992; Monuki et al., 1990; Suzuki et al., 1990]. In
addition, three class IV genes, Brn-3a, Brn-3b and Brn-3c, are
predominantly expressed in the nervous system [Gerrero et al., 1993;
He et al., 1989; Lillycrop et al., 1992], as is the sole class VI gene,
Emb/Brn-5 [Andersen et al., 1993; Okamoto et al., 1993].
Transcripts of most of these genes are found in the developing
neural tube, which makes them candidates for trans-acting
regulators of the nestin gene. Three POU-III members (Brn-1, Brn-2,
and Brn-4) are widely expressed in the developing neural tube from
about 10.5 days post-coitum (E10.5) in the rat [Alvarez-Bolado et al.,
1995]. Translation of Brn-2 begins prior to E8.5, when the protein is
found in limited areas of the neural folds [Schonemann et al., 1995].
The early onset and wide expression of Brn-1, Brn-2, and Brn-4 in
the neural tube is reminiscent of nestin, which is first detected at
E7.75 in limited areas of the neural plate [Dahlstrand et al., 1995].
The fourth POU-III member, Tst-1, is much more restricted early in
development. It expands from a single tiny patch ventral to the optic
stalk at E10 [Alvarez-Bolado et al., 1995] to weakly mark several
discrete areas of the telencephalon, mesencephalon, and spinal cord
at E13, and is limited to the forebrain and brainstem at E16 [Treacy
and Rosenfeld, 1992]. This contrasts with the very widespread
expression of Tst-1 in the adult brain [Alvarez-Bolado et al., 1995].
Brn-3a is also strongly expressed in the developing CNS. In
contrast to Brn-1 and Brn-2, its expression is discontinuous, localized
to discrete regions of the mesencephalon, rhombencephalon, and
spinal cord, as well as outside the CNS in the trigeminal and dorsal
root ganglia [Treacy and Rosenfeld, 1992]. The class VI gene Emb is
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detectable in the CNS as early as E10 in the mouse, and is found
diffusely through the neural tube and stronger in the spinal cord at
E13 [Okamoto et al., 1993].
Interestingly, two of the founding POU family members which
are restricted to other tissues in the adult are transiently expressed
in the neural tube. Pit-1 first appears in the neural plate and tube
from E10 to E13, then the signal is lost until it reappears at E16 in
the anterior pituitary [Treacy and Rosenfeld, 1992]. While Pit-1 has
been shown to be necessary for pituitary development, it may have
unknown functions for a very brief period in the neural tube.
Similarly, the Oct-2 gene is closely identified with differentiation of B
lymphocytes [Ko et al., 1988; Muller et al., 1988; Scheidereit et al.,
1988]. However, Oct-2 transcripts are found through the length of
the neural tube from at E13 and E16, and can also be found in a few
regions of the adult brain, including the hypothalamic
suprachiasmatic nucleus (SCN) and medial mammillary nucleus (MM)
[Treacy and Rosenfeld, 1992].
Thus the developing nervous system is the site of expression
for many POU family genes. It must come as no surprise that roles
have been found for several of these genes in the generation of the
mature central nervous system. The class III POU genes have been
shown to be involved in neural differentiation both in vitro and in
vivo. In P19 embryonal carcinoma cells, antisense inhibition of Brn-2
expression prevents differentiation by retinoic acid to the neuronal
phenotype, but does not stop expression of muscle markers [Fujii and
Hamada, 1993]. P19 cells can also be differentiated by fusion with L
cell fibroblasts, to generate a neuroepithelial-like cell which co-
expresses Brn-2 and nestin [Shimazaki et al., 1993]. This
differentiation seems to require the down-regulation of a class V POU
gene, Oct-3, which is expressed only in pluripotent early embryonic
cells and some germ cells [Okamoto et al., 1990; Rosner et al., 1990;
Sch61ler et al., 1990]. Other POU genes such as Brn-1, Tst-1, Brn-4,
and Emb are not expressed in P19 either before or after retinoic acid
differentiation [Fujii and Hamada, 1993] Their unimportance in P19
is counterbalanced by the observation that most neurons derived
from P19 are cholinergic [Jones-Villeneuve et al., 1983];
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differentiation of other neuronal types may require other
transcription factors. Brn-4 is important in Xenopus laevis , where its
homolog XlPOU2 is activated by the neural inducer noggin and has
direct neuralizing activity in isolated ectoderm [Witta et al., 1995].
Finally, Brn-2 has been shown to be required for the terminal
differentiation and survival of specific neuronal lineages. The
disruption of this gene by homologous recombination results in the
loss of the paraventricular nucleus (PVH) and supraoptic nucleus (SO)
of the hypothalamus as well as the posterior pituitary [Nakai et al.,
11995; Schonemann et al., 1995]. The neuroendocrine cells of these
two nuclei die either during migration [Nakai et al., 1995], or
following migration and the failure of terminal differentiation
[Schonemann et al., 1995]. No other brain regions are grossly
abnormal, and no disruption of development is seen prior to E12.5.
However, Brn-2 is expressed in the forebrain as early as E8.5. Its
function in other brain regions, and in hypothalamus prior to E12.5,
is likely to be complemented in knockout animals by redundant
genes. Since the primordium of the hypothalamus adjacent to the
third ventricle co-expresses Brn-1, Brn-2, and Brn-4, it seems
possible that POU-III proteins have overlapping functions to a
certain extent [Schonemann et al., 1995].
Among the functions of the POU-III proteins may be the
transcriptional regulation of the nestin gene. We have discussed a
good deal of circumstantial evidence for this role, from the
widespread expression of Brn-1, Brn-2 and Brn-4 in the early neural
tube to the co-expression of Brn-2 and nestin in the neural
differentiation of P19 cells. The work presented in this chapter tests
the hypothesis that the nestin CNS-specific element is bound in vitro
by POU-III family proteins.
This test is performed by modifying the familiar gel shift
assays of the previous chapter. Proteins which bind to labeled DNA
probes slow their migration through a nondenaturing gel; when
antibodies to the binding protein are added, the size of the complex
may be increased. The antibody-containing complex migrates more
slowly and is called a supershift. Alternatively, the antibody may
block interaction of the protein with DNA and cause the loss of the
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shifted band. Supershift assays are an excellent method to identify
proteins which bind a sequence of interest in vitro, as the high
specificity of antibodies for their epitopes allows accurate




Supershift assays were identical to the EMSAs reported in the
previous chapter, except that antibody was added to the protein-DNA
binding reactions after 30 minutes at room temperature, and
incubated a further 30 minutes before gel loading.
]Protein binding reactions were performed by combiningl0,000 cpm
of double-stranded oligonucleotide probe and 4 ggs of tissue nuclear
extract with 2.2 jggs poly(dI-dC) and 6.0 jggs BSA in binding buffer
(12% glycerol [vol/vol], 12 mM N-2-hydroxyethylpiperazine-N'-2-
ethanesulfonic acid [HEPES] [pH 7.9], 4 mM Tris-HCl [pH 7.9], 60 mM
KC1, 1 mM EDTA, 1mM dithiothreitol [DTT].) The binding reaction
proceeded at room temperature (230 C) for 30 minutes before
antibody addition, then was incubated another 30 minutes before gel
loading. Binding reactions were electrophoresed at 200 volts on a 4%
80:1 acrylamide/bis-acrylamide/2.5% glycerol gel.
A second supershifting method was also attempted for antibodies
which produced no supershifts by the method above. 1 gL of
antibody was mixed with 4 gjgs of tissue nuclear extract and TBST
(10mM Tris-HCI [pH 7.9], 150mM NaCl, 0.05% Tween-20) tolO gLs.
This was incubated 60 minutes on ice prior to the addition of 2.2 gigs
poly(dI-dC) and 6.0 jggs BSA in 10 giLs 2x binding buffer. This
mixture was incubated 10 minutes on ice before addition of 10,000
cpm of labeled probe, and kept on ice 15 minutes prior to gel loading.
Binding reactions were electrophoresed at 200 volts on a 4% 80:1
acrylamide/bis-acrylamide/2.5% glycerol gel at 40 C. Gels were dried
1 hour at 800 C and examined on a Molecular Dynamics
P)hosphorImager.
Antibodies used for supershift assays:
11G2: guinea pig anti-Brain-i




These antibodies were the generous gift of Dr. Michael G. Rosenfeld.
Each was diluted 1 to 10 in 10 mM Tris-HC1 [pH 8.0], 1 mM EDTA
before use.
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RXRP: rabbit anti-9-cis-Retinoic Acid Receptor beta (RXRP)
This antibody was used undiluted, and was the kind gift of Dr. Keiko
Ozato.
3B5: mouse anti-AP-2
This antibody was used undiluted. It was a magnanimous gift from
Dr. Trevor 'Wrilliams.
Anti-CREB and anti-phosphoCREB antibodies were purchased from
PNew England Biolabs, a second anti-phosphoCREB antibody from
Upstate Biotechnical, and anti-c-fos from Oncogene Science. Each was
used as a 1:10 dilution in 10 mM Tris-HCl [pH 8.0], 1 mM EDTA.
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Results
Brn-1 and Brn-2 bind to both octamer sites of the nestin
enhancer
Supershift assays were performed to determine whether any of
the complexes on the two octamer-containing probes are formed by
class III POU proteins. Antibodies to the four POU-III proteins
(Brn-1, Brn-2, Tst-1 and Brn-4) were kindly provided by Dr. M.G.
Rosenfeld. The double-stranded oligonucleotide probes used here are
the same ones described in the previous chapter as "footprint 1" and
"footprint 4". These probes were mixed with cortical extracts prior to
addition of antibodies.
Figure 19 shows a supershift assay in which antibodies were
added to identical binding reactions composed of labeled footprint 1
probe and E17 rat cortex nuclear extract. Lane 1 shows that in the
absence of any antibody, E17 cortical tissue produces five strong
complexes on the footprint 1 probe. Lane two shows that addition of
antibody to Brn-1 blocks the formation of the uppermost complex
seen in lane 1, and produces a supershifted complex which has
migrated only a short distance from the top of the gel (arrowhead). It
appears that the Brn-1 antibody has bound to just one protein-DNA
complex and greatly slowed its rate of migration. Therefore, this
complex is labeled Brn-1 at the left of the figure.
Similarly, addition of Brn-2 antibody in lane 3 blocks the
formation of two complexes seen with cortical extract alone.
However, the supershifted complex in lane 3 contains less labeled
DNA than that in lane 2. This indicates that the Brn-2 antibody may
be interfering with the binding of DNA by its target protein. The two
complexes which contain Brn-2 are marked at the left. The difference
between the two complexes may arise from phosphorylation, binding
of a co-factor, or alternative forms of Brn-2 itself.
Antibodies to Tst-1 and Brn-4 neither supershift nor interfere
with the formation of any of the complexes seen here. Neither does
an antibody to the 9-cis-retinoic acid P receptor (RXRP), provided by
Dr. K. Ozato and used here as a negative control. The last two lanes of
the figure are a competion experiment which shows that all five
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protein-DNA complexes demonstrate sequence-specific binding to the
footprint 1 probe.
The complexes formed on the other octamer-containing probe,
Ftpt4, are virtually identical with those on Ftptl. E17 cortical extract
forms five complexes of very similar mobilities on each of the two
probes (compare figures 19 and 20). Addition of antibodies show
that once again, Brn-1 forms one of these complexes and Brn-2 forms
another two. Binding of Tst-1, Brn-4, and RXRP are not detected.
Although their octamer-like sequences differ, the probes footprint 1
and footprint 2 bind the same proteins present in the E17 rat cortex.
Binding of Brn-1 and Brn-2 persists through cortical
development while other octamer-binding activities abate
Figure 21 shows a series of supershift assays performed on the
footprint 4 probe using cortical extract from E13 rats. The protein-
DNA complexes formed by E13 cortex are very similar to those
detected at E17, except an for an additional slow-migrating complex.
Supershift assays show that one Brn-i complex and two Brn-2
complexes are again formed at E13. Antibodies to Tst-1 and Brn-4 do
not block formation of any of the six complexes, leaving three
unidentified.
By postnatal day 5, only two strong complexes remain (see
figure 22). Antibody supershifts reveal that these two bands are
formed by Brn-i and Brn-2. A third complex is detected migrating
just faster than Brn-2, and is most visible when the Brn-2 band is
removed by supershifting (lane 3). This activity may be supershifted
by addition of antibody to Tst-1, but confirmation of this may
require a double supershift with antibodies to Brn-2 and Tst-1.
Supershift assays were also attempted on the footprint 1 and 4
probes using an antibody to the class I POU protein Pit-1, which is
transiently expressed in the developing CNS. However, Pit-1 antibody
did not recognize any complexes formed by E13 or E17 cortical
extracts on either probe (data not shown).
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Activities which recognize other binding sites of the nestin
enhancer are not identified by supershift assays
The oligonucleotide probes Ftpt2 and Ftpt3 contain sequences
similar to the recognition motif for AP-2 proteins (see chapter III).
An antibody raised against the AP-2a protein was provided by Dr. T.
Williams and used in supershift assays. Both probes are strongly
bound by proteins present in E16 rat spinal cord which are not
recognized by the AP-2a antibody (data not shown.)
The probe footprint 5 contains a binding site similar to the
cAMP response element or the half-site for non-steroid nuclear
receptors (see chapter III). E17 rat cortex nuclear extract produces
two strong complexes on this probe. Antibodies against RXRf3, c-fos,
Brn-1, CREB, and two antibodies against serinel33-phosphorylated
CREB were used in efforts to supershift the footprint 5 probe, without
success (data not shown).
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Figure 19. Supershift assays show that Brn-1 and Brn-2
bind to the Ftptl probe in vitro
Supershift assays were performed by adding antibodies versus class
III POU proteins or RXRP to EMSAs. In lanes 2-6, antibodies were
added to identical EMSAs halfway through the incubation of protein
with DNA.
Lane 1: Gel shift with E17 rat cortex nuclear extract on the labeled
Ftptl probe produces five abundant protein-DNA complexes.
Lane 2: antibody versus Brn-1 protein inhibits formation of the
uppermost complex (marked Brn-1 at left), and produces instead a
much slower-migrating complex at the top of the gel (arrowhead at
left of figure).
Lane 3: antibody versus Brn-2 protein inhibits formation of two
complexes, both marked Brn-2 at the left of the figure. A diffuse set
of supershifted bands appears near the top of the gel.
Lanes 4-6: antibodies versus Tst-1, Brn-4, or RXRP have no effect on
the typical EMSA pattern.
Lanes 7 and 8 demonstrate that all five complexes bind in a
sequence specific manner to the Ftptl probe. The unlabeled
competitor is Ftptl in lane 7, and TREp in lane 8. Both are added at
500-fold molar excess over labeled probe.
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Figure 20. Brn-1 and Brn-2 form complexes on the Ftpt4
probe very similar to those on Ftptl
Supershift assays with antibodies to class III POU proteins and RXRI
on the Ftpt4 probe.
Lane 1: in the absence of antibody, E17 rat cortex nuclear extract
forms five complexes with the labeled Ftpt4 probe. These are similar
in mobility and relative abundance to the complexes detected with
the Ftptl probe (figure 19).
Lane 2: antibody versus Brn-1 inhibits formation of the slowest-
migrating complex and produces a supershift (arrowhead at left of
figure).
Lane 3: antibody versus Brn-2 blocks formation of two complexes
and produces a diffuse set of supershifted bands.
Lanes 4-6: antibodies against Tst-1, Brn-4, or RXRP have no
detectable effect on any of the five protein-DNA complexes.
Lanes 7 and 8 demonstrate that all five complexes bind in a
sequence specific manner to the Ftpt4 probe. The unlabeled
competitors are Ftpt4 in lane 7, TREp in lane 8. Both are added at
500-fold molar excess over labeled probe.
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Figure 21. Brn-1 and Brn-2 binding activities are present in
telencephalon on embryonic day 13
Antibodies to class III POU proteins were added to incubations of
E13 rat telencephalon nuclear extract with labeled Ftpt4 probe.
Lane 1: E13 telencephalon proteins produce six complexes with Ftpt4.
Five of these correspond to bands produced by E17 cortex (figure
20), while the slowest-migrating band is only detected at E13.
Lane 2: antibody versus Brn-l supershifts one band, corresponding
to the Brn-l complex present at E17.
Lane 3: antibody versus Brn-2 supershifts two bands corresponding
to the two Brn-2 complexes detected at E17.
Lanes 3 and 4: antibodies to Tst-l and Brn-4 do not affect any of the
six complexes produced by E13 telencephalon extract.
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Figure 22. Brn-1 and a single Brn-2 binding activity persist
in cortex on postnatal day 5
Antibodies to class III POU proteins were added to Ftpt4 binding
reactions with P5 rat cortex nuclear extract.
Lane 1: only two strong binding activities for Ftpt4 are detected in
P5 cortex extract.
Lane 2: antibody versus Brn-1 completely displaces the slower-
migrating complex and produces a prominent supershift
(arrowhead).
Lane 3: antibody versus Brn-2 inhibits the faster-migrating complex
and produces a supershift. When the Brn-2 complex is displaced, a
fainter band is visible which runs only slightly ahead of the Brn-2
band in lane 1.
Lane 4: antibody versus Tst-1 appears to displace the weak complex
which runs just ahead of Brn-2 (compare doublet in lane 1 with lanes
3 and 4).
Lane 5: antibody versus Brn-4 has no detectable effect on any of the
bands produced by P5 cortex.
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Antibody supershift assays are a very powerful method for
identifying DNA-binding proteins in vitro. Assuming that antibodies
to candidate transcription factors are available from colleagues,
supershift assays are simpler and faster than using an
oligonucleotide probe to purify a binding protein or screen an
expression library. Also, the precision of the identification made by a
supershift is as good as the specificity of the antibody itself. Another
simple means of identifying a cis-acting element is to assay it for
binding by a purified transcription factor; however such an
identification is tenuous because multiple factors within a given
family can usually bind to the same site, and members of different
families sometimes cooperate or compete for binding to a single site.
Supershift assays are therefore the best method for discriminating
among several members of a known transcription factor family.
Numerous members of the POU transcription factor family are
good candidates for binding to the two octamer-like sites of the
nestin neural enhancer. Supershift assays have identified two of
these, Brn-i and Brn-2, among the activities which recognize both
octamer sites in rat CNS extracts. Both proteins are detected by
supershifts through the period of neurogenesis in the cortex: in E13
telencephalon, E17 cortex, and P5 cortex. Furthermore, the two slow-
migrating bands identified as Brn-i and Brn-2 by antibody are
present in gel shifts using extracts from all levels of the neural tube
(see figure 12).
Brn-2 is also detected in the E13 and E17 telencephalon as a
faster-migrating complex of lower abundance (figures 19-21). This
form of Brn-2 activity, along with two unidentified bands of similar
mobilities, appears to be specific to the forebrain (figure 12). This
second activity is not detected at P5, an age by which neurogenesis
in the cortex has ended [Berry et al., 1964]. Perhaps the difference
between the transient and persistent forms of Brn-2 could be
detected in immunoprecipitation assays to look for phosphorylation
or associated proteins.
Another significant feature of Brn-1 and Brn-2 binding
revealed by supershifting is that the two proteins are not present in
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a single complex with DNA. This suggests either that these two
proteins compete for binding to the Ftptl and Ftpt4 sites or that they
are not present in the same cells. Extensive co-expression of Brn-1
and Brn-2 has been shown by in situ hybridization [Alvarez-Bolado
et al., 1995], so it seems likely that they compete.
Brn-1 and Brn-2 also appear to compete for binding to the two
octamers with several unidentified proteins. Supershift assays for
the other POU-III proteins revealed only a minor Tst-1 band at P5
(figure 22), and no Brn-4 binding was detected. Methylation
interference on the two octamer sites showed that all of the
isolatable complexes recognized the same bases (figure 16d), which
suggests that all contain POU proteins. Many of the known POU genes
are expressed in the brain at some period. This includes the
ubiquitous Oct-1, the transient CNS expression of Pit-1 and Oct-2
[Treacy and Rosenfeld, 1992], the three Brn-3 genes [Gerrero et al.,
1993; He et al., 1989; Lillycrop et al., 1992] and Brn-5/Emb
[Andersen et al., 1993] as well as the class III POUs assayed here. In
these experiments one binding activity was strong only at E13
(figure 21), so it was hypothesized to be Pit-1; however, antibody to
Pit-1 protein did not recognize any of the complexes on either
octamer probe.
Similarly, we have proposed several known transcription
factors as candidate binding activities for the other three footprinted
regions. Footprint 5 is suggested to be a cyclic AMP response element
or a non-steroid nuclear hormone receptor binding site, based on
sequence homologies and its inverted repeat structure. However, no
supershifts have yet been produced on this site using antibodies
against CREB, phosphorylated CREB, c-fos, or RXRP. Also, footprints 2
and 3 are proposed to be AP-2 binding sites, based on sequence
homology with the AP-2 consensus motif, and the predominance of
binding activity in the posterior CNS. Yet this binding activity is not
recognized by an antibody to AP-2.
These negative results with various antibodies do not
absolutely rule out the tentative identifications of transcription
factors which we have made. First, not all antibodies are capable of
supershifting their target protein. This may be because some
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antibodies are generated against denatured proteins or peptide
fragments for use in western blots, and cannot recognize their
epitope under non-denaturing conditions. Alternatively, the binding
conditions for gel shifts may not be compatible in other ways with
the antibody's function. Second, consensus binding motifs are usually
recognized by a number of related transcription factors, while the
antibodies are specific to one or a few factors.
For example, one of the CREB antibodies used here binds an
epitope common to CREB, CREM, and ATF-1 [Ginty et al., 1993]. The
antibody recognizes all three proteins in western blots, but its range
in supershifts is unknown. However, there are additional proteins in
this family which also recognize the same DNA sequence [reviewed
by Meyer and Habener, 1993]. This site also has homology to the
non-steroid hormone response elements. Although no supershift was
produced with an antibody to RXRP, this is only one of three RXRs
which are promiscuous heterodimerization partners for the retinoic
acid receptors(RARs), thyroid hormone receptors (T3Rs), and vitamin
D3 receptors (VDRs)[reviewed by Mangelsdorf and Evans, 1995]. In
addition, such sites can be bound by several dimeric or monomeric
orphan receptors. Finally, we have attempted to supershift footprints
2 and 3 with an antibody against the human AP-2, without success.
However, at least three proteins are known which bind AP-2 sites:
AP-2, AP-2r, and AP-2.2 [Chazaud et al., 1996; Moser et al., 1995;
Williams et al., 1988]. Thus the identification of all the binding
activities on the nestin enhancer could be a slow process.
On the other hand, it has been possible to make a few
successful guesses of candidate transcription factors. Class III POU
genes were proposed to bind the nestin enhancer, based on
recognition site homology, mRNA localization patterns, and co-
expression in the P19 cell line. Supershift assays then confirmed that
Brn-1 and Brn-2 bind to two footprinted sites of the second intron,
and also found a minor interaction with Tst-1 in postnatal tissue.
Interestingly, Brn-2 is observed in two forms: a transient binding
activity which appears to be specific to the early forebrain, and a
persistent activity found in all tested regions of the CNS during and
after neurogenesis. In addition, a few unidentified binding activities
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are detected on the same sites and are also present only during the
embryonic period. Further work is necessary to determine if these
are also POU proteins.
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Conclusions: A Model of the Nestin CNS-Specific Enhancer
Complex
The experiments presented here lead to a model of the nestin
neural enhancer and its associated transcription factors (see figure
23). The 257 base pairs of nestin's second intron which are sufficient
to drive CNS-specific expression in vivo include five nuclear protein
binding sites detected in vitro. Candidate trans-acting factors for
each of these sites have been proposed on the basis of homology to
known binding motifs.
Three factors which bind the nestin enhancer in vitro have
been positively identified by the use of antibodies. The POU family
proteins Brn-1 and Brn-2 interact with a pair of sequences similar to
the canonical octamer site. In postnatal brain, Tst-1 also binds these
sites. Each of these proteins forms a separate complex with DNA, and
probably competes with the others and at least one yet-unidentified
POU protein for binding to DNA. The two octamer-like sites flank a
pair of sites for an unknown factor which may be a member of the
AP-2 family. Both AP-2-like sites are fully occupied only in posterior
portions of the CNS such as spinal cord and cerebellum, which
strengthens the argument that the binding protein is one of the
caudally restricted AP-2a or ( proteins. A much weaker binding
activity for these two sites is detected in the E16 cortex; this could be
the related AP-2.2 protein which is highly expressed in forebrain
[Chazaud et al., 1996].
The fifth binding site in the nestin enhancer has homology to
two kinds of transcription factor motifs, the cAMP response element
and the half-site for non-steroid nuclear hormone receptors.
Heterodimers of thyroid hormone receptor (T3R) and 9-cis-retinoic
acid receptors (RXRs) sometimes bind a single half-site [Marks et al.,
1992], as do the monomeric orphan receptors NGFI-B and Nurrl
[Mangelsdorf and Evans, 1995]. However, the inverted repeat
structure of the binding site in the second intron augments its
resemblance to the cAMP response element. Such an element can be
bound by numerous proteins of the CRE-binding family or fos/jun
families in a variety of homo- or heterodimeric complexes.
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Figure 23. Model of the nestin CNS-specific enhancer
In vitro assays show that the nestin CNS-specific element is
composed of five footprinted sites within a region of 257 base pairs.
Ftpt 1 and Ftpt 4 are octamer-containing sites. Brn-1 and Brn-2
compete with each other for binding to these sites, and also with
Tst-1 and unidentified POU proteins. These sites are occupied in all
tested regions of the CNS, but some binding activities, including a
form of Brn-2, are found only in forebrain.
Ftpt 2 and Ftpt 3 are related to the consensus binding motif for
dimeric AP-2 proteins. These two sites are fully occupied only in
posterior CNS regions such as spinal cord and cerebellum.
Ftpt 5 is related to the cyclic AMP response element, and also to the
half-site for non-steroid nuclear hormone receptors. Therefore it
may be bound by dimeric CRE-binding proteins from the CREB or
AP-1 families, or by dimeric hormone receptors or monomeric
orphan receptors (nuclear hormone receptors, NHR in figure). One
binding activity for this site is present throughout the CNS, another is
found only in forebrain.
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Model of the CNS-Specific
Enhancer of the Nestin Gene







= CREB or NHR or AP-1?
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Table I: Summary of binding activities on the nestin CNS-
specific enhancer
This table summarizes information on the in vitro binding activities
for each of the five footprinted sites of the 257 bp CNS enhancer, and
the effects of deletion of sites in vivo. The five footprinted regions
are represented by five columns in the table.
Row 1 represents transgenic mice made with the construct
257gIITKlacZ (see figure 7). All five footprinted sites are contained in
the nestin genomic fragment of this construct. The pattern of
reporter expression in these mice is summarized at the right; lacZ
staining is seen throughout the CNS in all embryos which express the
enzyme.
Row 2 represents transgenic mice produced with a 70 bp deletion
from the enhancer (A RIRI NsiSalgIITKlacZ, see figure 4). The deletion
removes footprints 1 and 2, so the mice carry only footprints 3-5 of
the enhancer. Expression in these embryos is CNS-specific, but fills
the entire CNS in only one mouse. All others express in portions of
the CNS, mainly in midbrain or anterior CNS.
Row 3 represents transgenic mice made with an upstream portion of
the region most highly conserved between rat and human second
intron. This construct (gIICons5'TKlacZ) shares 136 bp with the 257
bp enhancer, including footprints 1-3 but not 4 or 5. Transgenic
embryos (see figure 6) show various ectopic patterns of expression;
half show staining of the spinal cord or spinal cord and midbrain in
addition to ectopic patches.
Row 4 summarizes results of EMSAs. Each of the five footprints is
bound by activities which are present in all tested regions of the CNS
as well as by activities with more limited expression domains.
Binding activities for footprints 2 and 3 are most prevalent in
cerebellum and spinal cord, but not limited to these areas. Footprints
1, 4, and 5 are recognized by binding activities which are limited to
the cortex.
Row 5 lists the best sequence homologies found for each footprint
based on methylation interference at the core binding sites. The
octamer is the consensus recognition motif for POU proteins; AP-2 is
the consensus site for a family of at least three AP-2 genes; CRE is
the cyclic AMP response element, and NHRE refers to a half-site
which mediates binding by nuclear hormone receptors.
Row 6 summarizes the results of antibody supershift assays. By this
method, the POU proteins Brn-1, Brn-2, and Tst-1 have been shown
to recognize the nestin CNS-specific enhancer in vitro.
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An interesting feature of the binding sites in the nestin CNS
enhancer is the occurrence of octamers and AP-2-like sites in pairs.
This suggests there may be cooperativity between the similar factors.
Some POU proteins such as Oct-2 and Pit-1 display cooperative
binding among multiple sites. There may also be interactions
between different transcription factor families on the enhancer, just
as Pit-1 functions synergistically with estrogen receptors or thyroid
hormone receptors on the enhancers of prolactin or growth hormone
genes [reviewed by Wegner et al., 1993]. Therefore, the correct
regulation of the nestin gene may depend on interactions between
similar and dissimilar proteins bound to the enhancer.
The 257 base pair enhancer which contains these five binding
sites is sufficient for CNS-specific expression at all embryonic ages
tested. Does the identification of potential trans-acting factors
indicate how this tissue-specific pattern is generated? Several of the
transcription factors being considered here can be induced by
intercellular signaling molecules, which suggests that nestin
expression may be regulated by such signals.
Retinoic acid is a good example of a signaling molecule which is
involved in CNS development and also induces some of our candidate
transcription factors. In P19 embryonal carcinoma cells, retinoic acid
induces expression of AP-2 and Brn-2, as well as nestin. The
expression of these trans-acting factors is required for differentiation
of P19 to a neuronal fate [Fujii and Hamada, 1993; Philipp et al.,
1994]. Retinoic acid can also alter CNS fates in vivo, leading to
anterior-posterior transformation of cell types in the Xenopus neural
tube [Durston et al., 1989; Sive et al., 1990] (see introduction).
In addition to being induced by retinoic acid, AP-2 is post-
translationally activated by phorbol ester stimulation of protein
kinase C or cAMP activation of protein kinase A [Imagawa et al.,
1987]. AP-2 is thus a part of two signal transduction pathways.
These two pathways also activate factors which may bind another
site in the nestin enhancer: CREB family members are activated by
cAMP-dependent phosphorylation, while AP-1 activity is increased
by phorbol ester [Kruijer et al., 1985]. In the human proenkephalin
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gene, an AP-2 site synergistically interacts with two CREs to increase
the responses to cAMP and phorbol esters [Hyman et al., 1989].
The protein kinase C pathway which activates AP-1 responds
to a number of extracellular signals, including basic fibroblast growth
factor (bFGF). Basic FGF induces expression of another CNS
intermediate filament, vimentin, via AP-1 sites [Carey and Zehner,
1995] and also stimulates proliferation of nestin- and vimentin-
expressing neural precursor cells [Vicario-Abejon et al., 1995]. AP-1
may therefore be a transcriptional activity which regulates both the
nestin gene and the proliferation state of neuroepithelial stem cells
in response to bFGF.
On the other hand, the expression patterns of Brn-1 and Brn-2
nearly parallel the pattern of nestin expression in the early neural
tube. The exception is the absence of these POU genes from the
dorsal hindbrain, where nestin is transcriptionally active. One might
conclude that the CNS-specific activity of the nestin second intron is
largely established by Brn-1 and Brn-2, with help from other factors
in the hindbrain. However, nestin expression is shut off in newborn
neurons while Brn-1 and Brn-2 persist in many neurons [Alvarez-
Bolado et al., 1995]. The down-regulation of nestin may be due to
changes in other transcription factors or members of the enhancer-
binding complex; the shutoff is not post-transcriptional, because the
heterologous reporter lacZ is similarly affected.
Another possibility is that the apparent competition between
Brn-1 and Brn-2 for binding to the two octamer sites is involved in
shutting off transcription. In P19 cells, Brn-2 and nestin are co-
expressed upon differentiation with retinoic acid [Fujii and Hamada,
1993], suggesting a positive effect of Brn-2 on nestin transcription.
Brn-1 is not expressed in P19, but in vivo has virtually the same
expression pattern as Brn-2 from the neural tube stage to adulthood
[Alvarez-Bolado et al., 1995]. Perhaps Brn-1 opposes the action of
Brn-2, with the balance of activity between the co-expressed
proteins determined by association with additional factors or changes
in phosphorylation. On the other hand, the two POU proteins may be
merely redundant in most cells, as deletion of the Brn-2 gene affects
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only a few nuclei of the hypothalamus [Nakai et al., 1995;
Schonemann et al., 1995].
The balance of Brn-1, Brn-2, and other POU-III genes present
in a neuroepithelial cell may also have important implications for
that cell's developmental potential. [Alvarez-Bolado et al., 1995]
have painstakingly mapped expression of the four class III POU
genes in the developing forebrain, and conclude that these genes are
involved in dividing the neural tube into numerous subregions. For
example, Brn-4 expression distinguishes the diencephalon from the
telencephalon before an anatomical boundary is apparent. Later,
both of these regions are fragmented into small areas expressing
distinct combinations of Brn-1, Brn-2, Tst-1 and Brn-4 which often
foreshadow anatomical divisions. However, these regions defined by
combinations of POU-III genes do not correspond to the neuromeric
divisions of the forebrain described elsewhere [Figdor and Stern,
1993; Puelles and Rubinstein, 1993].
If combinatorial patterns of Brn-1 and Brn-2 establish the
neural expression domain of the nestin gene, deletion of their
octamer recognition sites ought to block CNS-specific expression.
Generation of transgenic mice with such a mutated enhancer is
underway, but previous in vivo results with partial nestin enhancers
could be informative. In chapter 2, transgenic mice were made with
the upstream portion of a sequence highly conserved between rat
and human nestin second introns (gIICons5'TKlacZ, figure 6). This
construct contains the first three footprinted sites of the nestin
enhancer and lacks footprints 4 and 5 (see Table I). The effect on
tissue-specific expression of removing one octamer site and one CRE
or nuclear receptor half-site is severe. Four embryos stained for lacZ,
and all four expressed it in different regions outside the CNS.
However, two embryos also had expression in the CNS. One shows
strong staining of the spinal cord and hindbrain only, and the other
has relatively weak staining in the midbrain and portions of the
spinal cord (figure 6). Therefore, footprints 4 and 5 are necessary for
CNS-specific expression, although the other three cis-elements can
sometimes produce expression in the posterior CNS.
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The effect of deleting footprinted sites 1 and 2 was also
reported in chapter 2 (A RIRINsiSal gIITKlacZ, figure 4). Deletion of 70
base pairs from the enhancer region in this reporter construct
removed one octamer site and one AP-2-like site (see Table I). The
lacZ reporter in these mice is still expressed specifically in the CNS,
perhaps because one octamer, one AP-2-like site, and footprint 5
remain. However, most of the mice express lacZ at much lower levels
in the spinal cord than in the head. This suggests that expression in
the spinal cord may depend on different cis-elements than does
expression in the anterior CNS. However, both transgenic constructs
reported here include second intron sequences from outside the 257
bp element. These may partially compensate for missing binding
sites.
The five identified binding sites of the nestin enhancer seem to
recognize different sets of trans-acting factors in different brain
regions (see Table I). DNAse I footprinting and gel shift assays show
variations in the enhancer binding activities detected in the cortex,
midbrain, cerebellum and spinal cord. Some proteins, such as Brn-1
and Brn-2, are detected in similar quantities in all four tissues. In
contrast, an AP-2-like activity is strongly present in cerebellum and
spinal cord but weak or undetectable in midbrain and cortex. The
AP-2 genes a and 3 have been reported to be expressed in the E13.5
mouse CNS at all levels except the forebrain [Moser et al., 1995],
while a third family member, AP-2.2, is expressed specifically in
forebrain at the same age [Chazaud et al., 1996]. Two strong binding
activities are detected on the CRE-like footprint 5; one is present in
all four brain regions tested and the other is detected only in extracts
from cortex (see figure 13). Similarly, a group of three binding
activites for the two octamer-containing footprints 1 and 4 are found
only in cortex during neurogenesis (figure 12). One of these activities
is a form of Brn-2 (figures 19-21). Thus the complex of proteins
formed on the nestin enhancer in vivo may have different
components in various brain regions.
This requirement for distinct sets of transcription factors in
different regions of the brain to produce continuous nestin
expression throughout the neural tube could reflect the evolutionary
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history of the brain. The size and complexity of the mammalian
forebrain has increased with time. However, many of the
transcription factors expressed in the mammalian forebrain are
homologs of the genes which pattern the fly head, such as
orthodenticle, empty spiracles, and distalless [Finkelstein and
Boncinelli, 1994]. Perhaps the transcriptional complex on the
enhancer of an ancestral nestin-like gene evolved in parallel, adding
new factors in the forebrain which increase the proliferation of
forebrain precursors.
Finally, in situ hybridization studies have shown that nestin
expression does occur in some areas of the adult brain. These areas
include the subventricular zone, which is the proliferative region of
the forebrain in the late embryonic period; the piriform cortex; the
olfactory bulb and primary olfactory cortex; the arcuate and
paraventricular nuclei of the hypothalamus; and subsets of basal
forebrain nuclei [Dugich-Djordjevic et al., in preparation]. In addition,
nestin can be found in the adult brain in EGF-responsive precursors,
reactive astrocytes, and some tumor types [Clarke et al., 1994; Craig
et al., 1996; Dahlstrand et al., 1992]. Nestin marks proliferating
populations in the adult subventricular zone and hypothalamus,
while cell division is not detected in the other nestin-expressing
regions of the normal adult brain. Many of these same adult brain
regions also express the POU-III genes Brn-1, Brn-2, or Brn-4
[Alvarez-Bolado et al., 1995]. We are currently investigating whether
these POU proteins co-localize with nestin expression in the adult,
and whether this nestin expression is dependent on the second
intron enhancer. Furthermore, we wish to know whether the POU
proteins are part of the pathway which controls the proliferation of
precursors in the adult brain in response to growth factors or brain
injury.
The results presented here could be extended in a number of
interesting directions by additional experiments. First, several nestin
enhancer-binding proteins remain to be identified, and these are
being pursued by supershift assays with antibodies to the three
known AP-2 family members and other proteins. For footprint 5,
which is similar to binding motifs of several transcription factor
151
families, the list of candidate proteins may be narrowed down by
cross-linking protein to its bromodeoxyuridine-substituted binding
site with ultraviolet light and determining the molecular weight of
the bound protein on a denaturing protein gel [Lin and Riggs, 1974].
Some of the unidentified binding activities may be novel factors; it
could be worthwhile to screen an embryonic brain expression library
with binding site probes.
Another group of experiments which is underway follows up
on the idea that individual binding sites of the nestin enhancer may
be required for expression in only some portions of the central
nervous system. Transgenic mice are being made from a 1.8 kb
nestin second intron-TK promoter-lacZ reporter construct with single
binding sites mutated. Analysis of these mice at various ages may
also suggest whether the extinction of nestin expression is simply the
reverse of transcriptional initiation or requires a separate silencing
site. Silencing of expression could also require new negative
transcriptional regulators which may compete with positive
regulators for binding to the enhancer. It is possible to test the
positive or negative effects of the identified enhancer-binding factors
by co-transfecting cDNAs for these into cell lines along with a nestin
enhancer-lacZ or -chloramphenicol acetyltransferase (CAT) reporter
construct to quantitatively measure the effects of these factors on
transcription. Of course, different factors may be rate-limiting at
different times in the life of a precursor cell. It would therefore be
best to perform the cotransfection assay not only in a nestin-
expressing cell line such as ST15A, but also in committed cell lines
and in embryonic stem cells, which do not express nestin but can be
induced to do so [Shimazaki et al., 1993].
Furthermore, the positive or negative influence of any single
factor on nestin transcription may be less important than the
combinatorial interactions among multiple transcription factors. The
data presented here suggests that some of the nestin enhancer-
binding factors, such as the POU proteins Brn-1, Brn-2, and Tst-1
may compete with each other for binding to a single octamer site;
also, cooperative interactions may occur between POU proteins bound
to the two octamer sites, between proteins bound to the two AP-2-
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like sites, or between members of different transcription factor
families. Using purified protein, accurate equilibrium and kinetic
binding constants of protein-DNA interactions can be measured by a
quantitative gel shift assay [Chodosh et al., 1986]. In addition,
cooperative binding interactions among multiple DNA sites can be
assessed using a DNAse I footprint titration method [Brenowitz et al.,
One further level of complexity in nestin regulation suggested
by this work is the post-translational regulation of transcription
factor activity. A second form of Brn-2 was found in E13 and E17
telencephalon; this may represent a covalently modified form of the
factor, or indicate an associated cofactor. The difference between the
two forms of Brn-2 can be studied by immunoprecipitation with an
antibody to Brn-2, followed by electrophoresis and western blotting
to detect additional proteins or Brn-2 phosphorylation. Again,
quantitative binding assays could determine the effect of such
modification on Brn-2 activity.
In conclusion, the goal of this work has been to identify
transcription factors which regulate the nestin gene in the central
nervous system. Because nestin expression is very tightly linked to
proliferation, it was anticipated that this study would detect
transcription factors important in specifying multipotential precursor
cells and driving their division or differentiation. The results indicate
that expression of nestin in the developing CNS is directed by a 257
base pair enhancer containing recognition sites for factors of the POU
domain, AP-2, and CRE-binding or nuclear hormone receptor families.
In vitro, the enhancer is bound by the POU domain proteins Brn-1,
Brn-2, and Tst-1, as well as unknown factors.
The identification of these POU proteins supports the
hypothesis that nestin is transcriptionally linked to significant
developmental events. A requirement for Brn-2 has been
demonstrated in the terminal differentiation of specific neurons in
vitro [Fujii and Hamada, 1993] and in vivo [Nakai et al., 1995;
Schonemann et al., 1995], and all four class III POU proteins have
also been proposed to function in forebrain patterning [Alvarez-
Bolado et al., 1995]. Thus the transcription factors identified in this
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analysis illustrate that proteins which interact with the nestin
enhancer can regulate not only processes common to all precursor
cells, such as proliferation or terminal differentiation, but also the
regionalizing processes which distinguish the progeny of one neural
precursor from those of its neighbor. In addition, nestin-expressing
precursor cells have now been identified in the adult brain. Further
study of the transcriptional regulators of this intermediate filament
could one day explain the processes which separate the quiescence of
precursor cells in the normal adult brain from the rapid proliferation
of injury-responsive cells or brain tumors.
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